var title_f31_62_32736="Cat scratch macular star";
var content_f31_62_32736=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F69294&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F69294&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 584px\">",
"   <div class=\"ttl\">",
"    Macular star from ocular involvement with cat scratch disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 564px; height: 273px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Exudates are seen overlying the macula, and some are radiating outward from the foveal area. This is referred to as a macular star. The appearance is characteristic of cat scratch disease with ocular involvement.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of James T Rosenbaum, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_62_32736=[""].join("\n");
var outline_f31_62_32736=null;
var title_f31_62_32737="Kleinert finger splint in place";
var content_f31_62_32737=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F83566&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F83566&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Kleinert finger splint in place",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 405px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The photograph above shows the Kleinert splint in position. The splint should keep the distal interphalangeal joint in slight hyperextension without placing any direct pressure on the joint itself.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Rebecca Bassett, MD",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_62_32737=[""].join("\n");
var outline_f31_62_32737=null;
var title_f31_62_32738="Patient information: Dehydration (The Basics)";
var content_f31_62_32738=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?9/5/9299\">",
"         Patient information: Diarrhea in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?33/34/34338\">",
"         Patient information: Diarrhea in children (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?36/15/37105\">",
"         Patient information: Heat stroke (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?27/57/28562\">",
"         Patient information: Nausea and vomiting in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?27/13/27858\">",
"         Patient information: Rotavirus infection (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?9/3/9267\">",
"         Patient information: Viral gastroenteritis (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?35/29/36308\">",
"         Patient information: Acute diarrhea in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?0/1/27\">",
"         Patient information: Acute diarrhea in children (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?21/54/22371\">",
"         Patient information: Nausea and vomiting in infants and children (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Dehydration (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/dehydration-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H11005459\">",
"      <span class=\"h1\">",
"       What is dehydration?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Dehydration is the term doctors use when the body loses too much water. Losing too much water is a problem, because our bodies need a certain amount of water to work normally. Another word your doctor might use when you lose too much water is &ldquo;hypovolemia.&rdquo;",
"     </p>",
"     <p>",
"      Dehydration can be mild or severe. Mild dehydration doesn&rsquo;t usually cause problems. But if mild dehydration isn&rsquo;t treated, it can get worse. Severe dehydration is a medical emergency and can be life-threatening.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11005474\">",
"      <span class=\"h1\">",
"       What causes dehydration?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Dehydration happens when your body loses more water than you take in from drinking and eating.",
"     </p>",
"     <p>",
"      It&rsquo;s normal for people to lose some water from their bodies every day, for example, in their urine and bowel movements. But some things make people lose a lot of water, including:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Vomiting",
"       </li>",
"       <li>",
"        Diarrhea",
"       </li>",
"       <li>",
"        Sweating a lot from heavy exercise",
"       </li>",
"       <li>",
"        A high fever",
"       </li>",
"       <li>",
"        Medicines called &ldquo;diuretics&rdquo; or &ldquo;laxatives&rdquo; &ndash; Diuretics make people urinate a lot. Laxatives can cause a lot of watery bowel movements.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Some things keep people from taking in enough water. For example, people might not drink or eat if they have an upset stomach or sore throat.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11005489\">",
"      <span class=\"h1\">",
"       What are the symptoms of dehydration?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People with mild dehydration might not notice any symptoms.",
"     </p>",
"     <p>",
"      As dehydration gets worse, it can cause symptoms such as:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Feeling thirsty",
"       </li>",
"       <li>",
"        Urinating less often, or having dark yellow or brown urine",
"       </li>",
"       <li>",
"        A dry mouth or cracked lips",
"       </li>",
"       <li>",
"        No tears when a child cries",
"       </li>",
"       <li>",
"        Feeling tired or confused",
"       </li>",
"       <li>",
"        Feeling dizzy or light-headed",
"       </li>",
"       <li>",
"        Eyes that look sunken in the face",
"       </li>",
"       <li>",
"        A &ldquo;sunken fontanel&rdquo; (in babies) &ndash; A fontanel is a gap between the bones in a baby&rsquo;s skull. When babies are dehydrated, the fontanel on the top of their head can look or feel caved in.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Severe dehydration can make people stop breathing normally or go into a coma.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11005504\">",
"      <span class=\"h1\">",
"       Should I call a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Call the doctor or nurse if you or your child has any symptoms of dehydration.",
"     </p>",
"     <p>",
"      You should also call if you or your child:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Has diarrhea that lasts more than a few days",
"       </li>",
"       <li>",
"        Has vomiting that lasts more than 1 day",
"       </li>",
"       <li>",
"        Can&rsquo;t keep any fluids down",
"       </li>",
"       <li>",
"        Vomits blood or has bloody diarrhea",
"       </li>",
"       <li>",
"        Is urinating much more than usual",
"       </li>",
"       <li>",
"        Hasn&rsquo;t had anything to drink in many hours",
"       </li>",
"       <li>",
"        Hasn&rsquo;t needed to urinate in the past 6 to 8 hours (in adults and older children), or if your baby or young child hasn&rsquo;t had a wet diaper for 4 to 6 hours",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11005519\">",
"      <span class=\"h1\">",
"       Is there a test for dehydration?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Doctors can do blood and urine tests to check for dehydration and see how severe it is. Your doctor might also do tests to look for the cause of the dehydration.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11005536\">",
"      <span class=\"h1\">",
"       How is dehydration treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Dehydration is treated with fluids.",
"     </p>",
"     <p>",
"      People with severe dehydration usually need to be treated in the hospital. Treatment involves getting fluids through an &ldquo;IV&rdquo;, which is a thin tube that goes into the vein.",
"     </p>",
"     <p>",
"      People with mild dehydration can usually treat it on their own by drinking fluids. You&rsquo;ll know that the treatment is working when:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        You urinate more often and your urine looks pale yellow or clear.",
"       </li>",
"       <li>",
"        Your baby has more wet diapers.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Some fluids help treat dehydration better than water, because they give the body the right amount of water and salts. People should use the following fluids to treat dehydration:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Older children and adults can use sports drinks.",
"       </li>",
"       <li>",
"        You should give your baby or young child an &ldquo;oral rehydration solution,&rdquo; such as Pedialyte&reg;. You can buy this in a store or pharmacy. Try to give your child a few teaspoons of fluid every few minutes. If your baby won&rsquo;t drink it from a bottle or cup, you can feed him or her with a spoon or syringe.",
"       </li>",
"       <li>",
"        Babies who breastfeed should continue to breastfeed.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      People with dehydration should avoid drinking juice, soda, coffee, or other drinks with caffeine or a lot of sugar in them. These don&rsquo;t help treat dehydration. Plus, caffeine is a diuretic and makes people urinate more.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11005551\">",
"      <span class=\"h1\">",
"       Can dehydration be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. To help prevent dehydration, you can:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Drink plenty of fluids, especially if you are sick and have a fever.",
"       </li>",
"       <li>",
"        Give your baby or young child an oral rehydration solution as soon as he or she starts vomiting or having diarrhea.",
"       </li>",
"       <li>",
"        Drink extra fluids when you exercise or when it&rsquo;s hot out.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11005566\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/3/9267?source=see_link\">",
"       Patient information: Viral gastroenteritis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/5/9299?source=see_link\">",
"       Patient information: Diarrhea in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?33/34/34338?source=see_link\">",
"       Patient information: Diarrhea in children (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/57/28562?source=see_link\">",
"       Patient information: Nausea and vomiting in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/15/37105?source=see_link\">",
"       Patient information: Heat stroke (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/13/27858?source=see_link\">",
"       Patient information: Rotavirus infection (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/29/36308?source=see_link\">",
"       Patient information: Acute diarrhea in adults (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?0/1/27?source=see_link\">",
"       Patient information: Acute diarrhea in children (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?21/54/22371?source=see_link\">",
"       Patient information: Nausea and vomiting in infants and children (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?31/62/32738?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16940 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-122.72.76.133-0613BE51B3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_62_32738=[""].join("\n");
var outline_f31_62_32738=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11005459\">",
"      What is dehydration?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11005474\">",
"      What causes dehydration?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11005489\">",
"      What are the symptoms of dehydration?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11005504\">",
"      Should I call a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11005519\">",
"      Is there a test for dehydration?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11005536\">",
"      How is dehydration treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11005551\">",
"      Can dehydration be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11005566\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/29/36308?source=related_link\">",
"      Patient information: Acute diarrhea in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?0/1/27?source=related_link\">",
"      Patient information: Acute diarrhea in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/5/9299?source=related_link\">",
"      Patient information: Diarrhea in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?33/34/34338?source=related_link\">",
"      Patient information: Diarrhea in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/15/37105?source=related_link\">",
"      Patient information: Heat stroke (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/57/28562?source=related_link\">",
"      Patient information: Nausea and vomiting in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?21/54/22371?source=related_link\">",
"      Patient information: Nausea and vomiting in infants and children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/13/27858?source=related_link\">",
"      Patient information: Rotavirus infection (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/3/9267?source=related_link\">",
"      Patient information: Viral gastroenteritis (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_62_32739="Vulvar ulcers";
var content_f31_62_32739=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F68284&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F68284&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vulvar ulcers",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 388px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Pediatric and Adolescent Gynecology, 6th ed, Emans SJ, Laufer MR (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_62_32739=[""].join("\n");
var outline_f31_62_32739=null;
var title_f31_62_32740="Carisoprodol and aspirin: Patient drug information";
var content_f31_62_32740=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Carisoprodol and aspirin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/9/35990?source=see_link\">",
"     see \"Carisoprodol and aspirin: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10021823\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10021825\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691274",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to calm muscles.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10021824\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701726",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to carisoprodol, aspirin, meprobamate, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703363",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Bleeding problems, nose polyps, porphyria, or ulcer disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701061",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are more than 24 weeks pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10021829\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697693",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may be habit-forming with long-term use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697175",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have asthma, talk with your doctor. You may be more sensitive to this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10021830\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10021832\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699024",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699001",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Ringing in ears.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10021827\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is used with rest, PT (physical therapy), pain drugs, and other therapies.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10021828\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10021833\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10021834\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11775 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-41.196.66.12-562CF1C545-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_62_32740=[""].join("\n");
var outline_f31_62_32740=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021823\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021825\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021824\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021829\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021830\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021832\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021827\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021828\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021833\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021834\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?35/9/35990?source=related_link\">",
"      Carisoprodol and aspirin: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_62_32741="Venovenous ECMO";
var content_f31_62_32741=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F56622&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F56622&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 606px\">",
"   <div class=\"ttl\">",
"    Venovenous (VV) ECMO for isolated respiratory failure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 586px; height: 448px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Diagram of venovenous ECMO for respiratory failure. When there is no native lung function the arterial saturation will be 75 to 85 percent. VV access: Blood is withdrawn from the IVC, circulated through the artificial membrane, and returned via the SVC to the RA.",
"    <div class=\"footnotes\">",
"     ECMO: extracorporeal membrane oxygenation; AO: aorta; PV: pulmonary vein; PA: pulmonary artery; LA: left atrium; LV: left ventricle; RA: right atrium; RV: right ventricle; VV: venovenous; IVC: inferior vena cava; SVC: superior vena cava.",
"    </div>",
"    <div class=\"reference\">",
"     Revised and updated from: Bartlett RH, Gattinoni L. Current status of extracorporeal life support (ECMO) for cardiopulmonary failure. Minerva Anestesiol 2010; 76:534.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_62_32741=[""].join("\n");
var outline_f31_62_32741=null;
var title_f31_62_32742="Treatment of obstructive or substernal goiter";
var content_f31_62_32742=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of obstructive or substernal goiter",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/62/32742/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/62/32742/contributors\">",
"     Douglas S Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/62/32742/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/62/32742/contributors\">",
"     David S Cooper, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/62/32742/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/62/32742/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/62/32742/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 23, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Substernal goiter may be detected incidentally on chest x-ray or CT scan or found because of obstructive symptoms such as dyspnea, wheezing, or cough. The most common obstructive symptom is exertional dyspnea, which is present in 30 to 60 percent of cases, and usually occurs when the tracheal diameter is under 8 mm.",
"   </p>",
"   <p>",
"    The treatment of obstructive and substernal goiters will be reviewed here. The clinical manifestations and evaluation of substernal goiter, and the management of benign goiter are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/2/46?source=see_link\">",
"     \"Clinical manifestations and evaluation of obstructive or substernal goiter\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/0/22535?source=see_link\">",
"     \"Thyroid hormone suppressive therapy for thyroid nodules and benign goiter\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ANATOMIC RELATIONSHIPS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enlarging thyroid lobes usually grow outward, because of their location in the anterior neck in front of the trachea, covered only by thin muscles, subcutaneous tissue, and skin. In patients with substantial enlargement of one lobe or asymmetric enlargement of both lobes, the trachea, esophagus, or blood vessels may be displaced or, less often, compressed. Bilateral lobar enlargement, especially if the goiter extends posterior to the trachea, may cause either compression or concentric narrowing of the trachea or compression of the esophagus or jugular veins. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/17/44310?source=see_link\">",
"     \"Surgical anatomy of the thyroid gland\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    With some goiters, there is growth of one or both lobes through the thoracic inlet into the thoracic cavity, which can result in obstruction of any of the structures in the inlet (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef51935 graphicRef63758 \" href=\"mobipreview.htm?7/47/7927\">",
"     image 1A-B",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef79394 \" href=\"mobipreview.htm?34/40/35471\">",
"     figure 1",
"    </a>",
"    ). Such goiters are referred to as substernal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     SURGERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend surgery once obstructive symptoms are present because of the risk of further thyroid growth and progressive tracheal compression, which in some instances (eg, hemorrhage) may be rapid and fatal. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/2/46?source=see_link\">",
"     \"Clinical manifestations and evaluation of obstructive or substernal goiter\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The author of this topic and others suggest surgery for most patients with asymptomatic substernal goiters that extend below the level of the brachiocephalic vein, assuming they are good surgical candidates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/1-6\">",
"     1-6",
"    </a>",
"    ]. However, this is an area of controversy, and other experts prefer to monitor such patients.",
"   </p>",
"   <p>",
"    Patients with less extensive substernal goiter may be followed, but we suggest surgery for these patients if growth is detected on serial CT scans.",
"   </p>",
"   <p>",
"    The arguments for removing a substernal goiter in a patient who has no obstructive symptoms include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Some goiters continue to enlarge and become more difficult to remove if obstructive symptoms do develop. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/2/46?source=see_link\">",
"       \"Clinical manifestations and evaluation of obstructive or substernal goiter\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Suppressive therapy is relatively ineffective and is associated with significant morbidity in elderly patients. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Levothyroxine suppression'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Forty-two percent of patients with evidence of upper airway obstruction on flow-volume loops are asymptomatic [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      As patients age, surgical complications are more common and severe [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The substernal component could contain a cancer that cannot be palpated or biopsied (range of reported cancer risk 3 to 22 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/6,9\">",
"       6,9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      There is a small risk of hemorrhage into the goiter that could result in acute airway obstruction. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/2/46?source=see_link\">",
"       \"Clinical manifestations and evaluation of obstructive or substernal goiter\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are some patients who may be observed rather than undergo surgery, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Elderly asymptomatic patients who are poor operative candidates.",
"     </li>",
"     <li>",
"      Patients without thyroid enlargement whose glands extend slightly substernally due to kyphosis.",
"     </li>",
"     <li>",
"      Patients whose goiters extend only slightly substernally on a CT scan obtained without neck extension may not be substernal when the neck is extended. Their glands are also usually accessible for fine needle aspiration biopsy if indicated.",
"     </li>",
"     <li>",
"      Patients who, in retrospect, have serial CT scans showing long-term stability of a substernal goiter, especially if the inferior extent is above the level of the brachiocephalic vein.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Preoperative assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial evaluation of substernal goiter is discussed in detail separately and includes serum TSH to evaluate for subclinical or overt hyperthyroidism, imaging studies (CT or MRI) to evaluate the extent of the goiter and its effect upon surrounding structures, a flow-volume loop study, and fine needle aspiration biopsy if malignancy is suspected. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/2/46?source=see_link\">",
"     \"Clinical manifestations and evaluation of obstructive or substernal goiter\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The decision to proceed with surgery is usually made on the basis of symptoms, anatomic studies, and the results of a flow-volume loop study. Most goiters have benign thyroid aspirates.",
"   </p>",
"   <p>",
"    Once the decision to proceed with surgery has been made, other preoperative assessment of substernal goiter should include laryngoscopy to assess the tracheal lumen and vocal cord function. If the patient is hyperthyroid and surgery is elective, an antithyroid drug and, if not contraindicated, a beta blocker should be given for several weeks before surgery. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/8/12424?source=see_link&amp;anchor=H6#H6\">",
"     \"Surgery in the treatment of hyperthyroidism: Indications, preoperative preparation, and postoperative follow-up\", section on 'Preoperative preparation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Surgical approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of obstructive and substernal goiters can be excised through a standard cervical incision, while partial or complete sternotomy or even thoracotomy may be required in patients with previous cervical thyroidectomy, very large substernal goiters, or invasive cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. In an Italian study of 19,662 patients undergoing total thyroidectomy at six centers, 1055 had substernal goiters and only 69 (6.5 percent) required sternotomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/12\">",
"     12",
"    </a>",
"    ]. Patients requiring sternotomy were more likely to have a malignancy: 36 percent compared with 22 percent of those excised through a cervical incision. Similar results were noted in two single center studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/6,13\">",
"     6,13",
"    </a>",
"    ], and in a systematic review [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/9\">",
"     9",
"    </a>",
"    ]; recurrent or ectopic goiter in addition to malignancy were associated with the need for sternotomy.",
"   </p>",
"   <p>",
"    We suggest that all patients with substernal goiter be referred to an experienced thyroid surgeon, as complication rates appear to be lower in high volume centers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/14\">",
"     14",
"    </a>",
"    ]. Patients who may require sternotomy should be referred to an experienced thoracic surgeon.",
"   </p>",
"   <p>",
"    The extent of surgery for benign goiter depends upon the expertise of the surgeon, the extent of the goiter, and whether the patient has obstructive symptoms and signs. Because of the risk of recurrent goiter, a",
"    <strong>",
"     total or near-total thyroidectomy",
"    </strong>",
"    should be performed unless during the procedure the surgeon feels that a less extensive operation is prudent because of an increased risk of recurrent laryngeal nerve injury or hypoparathyroidism due to anatomic considerations. If a more limited operation is done, we suggest:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with large, relatively symmetric goiters should have a bilateral subtotal thyroidectomy.",
"     </li>",
"     <li>",
"      Patients with asymmetric goiters should have a hemithyroidectomy on the more involved side and a subtotal thyroidectomy on the contralateral side. If the patient already has vocal cord paralysis on the one side and the contralateral thyroid lobe is not very large, we suggest doing only a hemithyroidectomy and isthmusectomy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In patients with chronic autoimmune thyroiditis who have concentric tracheal compression, excision of the isthmus alone may be sufficient to alleviate the compression. These fibrous glands may be difficult to dissect free from nerves and parathyroid glands and more extensive surgery may result in complications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major complications of surgery for large goiters and substernal goiters are injury to the recurrent laryngeal nerves, trachea, and parathyroid glands [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/1-4,6,10,15\">",
"     1-4,6,10,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surgery for substernal goiter appears to be associated with higher complication rates than surgery for cervical goiter, as illustrated by a statewide database of cervical (n = 32,777) and substernal thyroidectomies (n = 1153) performed between 1998 and 2004. Patients who underwent substernal thyroidectomy were more likely to be older, have a comorbid condition, be uninsured, be undergoing total thyroidectomy, and have surgery at a low-volume center [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/8\">",
"     8",
"    </a>",
"    ]. After adjusting for these variables, patients undergoing substernal thyroidectomy were still at higher risk for the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Recurrent laryngeal nerve injury (OR 2.4, 95% CI 1.5-3.8)",
"     </li>",
"     <li>",
"      Postoperative bleeding (OR 1.9, 95% CI 1.2-2.9)",
"     </li>",
"     <li>",
"      Deep venous thrombosis (OR 5.9, 95% CI 2.4-15.2)",
"     </li>",
"     <li>",
"      Respiratory failure (OR 4.2, 95% CI 2.8-6.2)",
"     </li>",
"     <li>",
"      Red blood cell transfusion (OR 5.7, 95% CI 3.8-8.5)",
"     </li>",
"     <li>",
"      Mortality (OR 8.3, 95% CI 4.2-16.3)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the same database, complication rates were significantly lower at hospitals that performed a high volume of substernal thyroidectomies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Of note, this study did not report how many patients with substernal goiter required sternotomy, a procedure that may be associated with higher surgical complication rates. However, in the Italian study of 1055 patients with substernal goiter, 69 patients who required a sternotomy were compared with 986 patients whose goiters were excised through a cervical incision [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/12\">",
"     12",
"    </a>",
"    ]. Only phrenic nerve palsy was more common in the sternotomy group, suggesting that surgery for substernal goiter (using a cervical approach or sternotomy) is associated with higher complication rates than surgery for cervical goiter.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Recurrent laryngeal nerve injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transient recurrent laryngeal nerve injury has been reported to occur in 2 to 9 percent of patients undergoing surgery for substernal goiter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/6,10,11,15\">",
"     6,10,11,15",
"    </a>",
"    ]. Permanent nerve injury occurs less commonly: 0 and 0.03 percent in the two largest studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/6,15\">",
"     6,15",
"    </a>",
"    ] and 3 percent in two other reports [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Patients with bilateral nerve injury, and therefore bilateral vocal cord paralysis, require tracheostomy to provide an adequate airway.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Hypocalcemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypocalcemia due to hypoparathyroidism is the most frequent complication of near-total thyroidectomy, and is more common when the goiter is extensive and anatomic landmarks are displaced and obscured. Hypocalcemia may be transient or permanent. Transient hypoparathyroidism occurred in 12 of 170 patients (7 percent) in one series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Current requirements for short hospital stays argue for early treatment of hypocalcemia. Our approach to the management of hypocalcemia is summarized in the table and reviewed in detail separately (",
"    <a class=\"graphic graphic_table graphicRef59019 \" href=\"mobipreview.htm?28/57/29596\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/6/41064?source=see_link&amp;anchor=H16#H16\">",
"     \"Surgical treatment of differentiated thyroid cancer\", section on 'Hypoparathyroidism'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Tracheomalacia",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients who have tracheomalacia due to pressure-induced destruction of tracheal rings by the goiter, the airway may collapse during the postoperative period. In one study, 10 percent of patients could not be immediately extubated, although all were successfully extubated by 10 days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/16\">",
"     16",
"    </a>",
"    ]. These patients were older, had larger goiters, and were more likely to have tracheal compression. If recognized at the time of surgery, tracheomalacia may in some cases be treated by partial tracheal resection and reconstruction, otherwise, tracheostomy is necessary.",
"   </p>",
"   <p>",
"    In a systematic review, the presence of a substernal goiter for more than five years causing tracheal compression was a risk factor for tracheomalacia and tracheostomy. However, in this review, tracheomalacia was an infrequent occurrence (3 percent) and was managed without tracheostomy in approximately 50 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     LEVOTHYROXINE SUPPRESSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/43/41656?source=see_link\">",
"     Levothyroxine",
"    </a>",
"    may have a",
"    <strong>",
"     limited",
"    </strong>",
"    role in patients with substernal goiters. In a randomized trial, TSH-suppressive doses of levothyroxine reduced goiter size in about two-thirds of patients with sporadic multinodular goiters [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/17\">",
"     17",
"    </a>",
"    ]. However, most large goiters do not shrink sufficiently to alleviate symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/18\">",
"     18",
"    </a>",
"    ], any reduction in size is not rapid, and levothyroxine is not effective in those patients who already have low serum TSH concentrations (ie, subclinical hyperthyroidism). Additionally, growth of the goiter may resume as soon as levothyroxine treatment is stopped.",
"   </p>",
"   <p>",
"    The use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/43/41656?source=see_link\">",
"     levothyroxine",
"    </a>",
"    is controversial. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/0/22535?source=see_link\">",
"     \"Thyroid hormone suppressive therapy for thyroid nodules and benign goiter\"",
"    </a>",
"    .) The author of this topic suggests a trial of levothyroxine therapy in asymptomatic younger patients with normal serum TSH concentrations and no contraindications for suppressive therapy to attempt to reduce goiter size or prevent further growth. However, others do not use levothyroxine suppressive therapy for goiter.",
"   </p>",
"   <p>",
"    Treatment of patients with suppressive doses of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/43/41656?source=see_link\">",
"     levothyroxine",
"    </a>",
"    who have already had surgery for obstructive goiter (versus no therapy or replacement therapy if needed to normalize the serum TSH concentration) is also controversial. In one study with 10 years of follow-up, the recurrence rate was lower in the patients treated with levothyroxine (5 percent versus 42 percent in the untreated group had recurrent goiter) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/19\">",
"     19",
"    </a>",
"    ]. However, this benefit was not confirmed in a report with 30 years of follow-up: the recurrence rates were similar (41 and 45 percent) in treated and untreated patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/0/22535?source=see_link\">",
"     \"Thyroid hormone suppressive therapy for thyroid nodules and benign goiter\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We generally do not recommend post-operative suppressive therapy with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/43/41656?source=see_link\">",
"     levothyroxine",
"    </a>",
"    . However the author of this topic suggests a trial of suppressive therapy in young patients with no contraindications to suppression who experience growth of a surgical remnant.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     RADIOIODINE THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radioiodine (131-I) is a reasonable option for patients who cannot or do not want to undergo surgery, particularly if the substernal or obstructive goitrous tissue is functional on thyroid radionuclide imaging. In patients with nonobstructive multinodular goiter, radioiodine therapy results in goiter volume reductions in the range of 30 to 60 percent. Pretreatment with recombinant human TSH (rhTSH) allows treatment with lower doses of radioiodine for thyroid volume reduction but may result in a transient early increase in goiter size. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/27/32185?source=see_link&amp;anchor=H4#H4\">",
"     \"Diagnostic approach to and treatment of goiter in adults\", section on 'Recombinant human TSH'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Results of radioiodine therapy for obstructive goiter include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one series of 14 patients with large multinodular goiters, eight of whom had respiratory symptoms and eight of whom had substernal extension, all improved after treatment with 200 to 400",
"      <span class=\"nowrap\">",
"       microCi/g",
"      </span>",
"      of 131-I, and no patient had an acute exacerbation of obstructive symptoms [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Similar improvements in obstructive symptoms were seen in a series of 19 elderly patients treated with 100",
"      <span class=\"nowrap\">",
"       microCi/g",
"      </span>",
"      tissue (average total dose 70 mCi). Goiter volume decreased by 40 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Volume reduction of the cervical and substernal components is similar (30 percent in one study) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32742/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite the reasonable results with radioiodine, surgery is still the treatment of choice because of concerns that radiation thyroiditis might result in worsening of airway obstruction, and the need to rule out the diagnosis of carcinoma if the goiter is mostly substernal. However, for patients who are not surgical candidates, we suggest radioiodine therapy as an alternative approach.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Recombinant human TSH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Similar to results seen with smaller multinodular goiters, the addition of recombinant human TSH to radioiodine in patients with obstructive goiters results in a greater reduction in thyroid volume than radioiodine alone. However, rhTSH is not currently FDA approved for this indication and we do not recommend it pending additional clinical trials demonstrating safety and efficacy. This is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/27/32185?source=see_link&amp;anchor=H4#H4\">",
"     \"Diagnostic approach to and treatment of goiter in adults\", section on 'Recombinant human TSH'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    The most common complaint in patients with obstructive cervical or substernal goiter is exertional dyspnea, which is present in 30 to 60 percent of cases. This symptom usually occurs when the tracheal diameter is under 8 mm.",
"   </p>",
"   <p>",
"    Bilateral thyroid lobe enlargement, especially if the goiter extends posterior to the trachea, may cause either compression or concentric narrowing of the trachea or compression of the esophagus or jugular veins. With some goiters, there is growth of one or both lobes through the thoracic inlet into the thoracic cavity which can result in obstruction of any of the structures in the inlet (",
"    <a class=\"graphic graphic_figure graphicRef79394 \" href=\"mobipreview.htm?34/40/35471\">",
"     figure 1",
"    </a>",
"    ). Such goiters are referred to as substernal. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Anatomic relationships'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The decision to proceed with surgery is usually made on the basis of symptoms, anatomic studies, and the results of a flow-volume loop study. All patients requiring surgery for substernal goiter should be referred to experienced thyroid surgeons in high volume centers to minimize complication rates.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with symptoms require removal or ablation of the thyroid. We suggest surgery rather than RAI (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). The reduction in thyroid volume with RAI is only moderate, and there are theoretical concerns that RAI could acutely worsen obstruction or a missed malignancy. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Surgery'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'Radioiodine therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with obstructive symptoms who are poor surgical candidates, we suggest radioiodine therapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Radioiodine therapy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10\">",
"       'Levothyroxine suppression'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For asymptomatic patients with normal flow-volume loops whose goiters end at the level of the brachiocephalic vein or higher, we suggest observation (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"      <br/>",
"      <br/>",
"      Recommendations for asymptomatic patients with goiters that extend below the level of the brachiocephalic vein are controversial. The author of this topic suggests surgical excision for most patients except elderly patients and those who are poor operative candidates, while other experts suggest observation of asymptomatic patients.",
"     </li>",
"     <li>",
"      For most patients undergoing surgery, we suggest a total or near-total thyroidectomy rather than subtotal thyroidectomy to minimize the risk of recurrent goiter (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32742/abstract/1\">",
"      Katlic MR, Grillo HC, Wang CA. Substernal goiter. Analysis of 80 patients from Massachusetts General Hospital. Am J Surg 1985; 149:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32742/abstract/2\">",
"      Allo MD, Thompson NW. Rationale for the operative management of substernal goiters. Surgery 1983; 94:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32742/abstract/3\">",
"      Miller MR, Pincock AC, Oates GD, et al. Upper airway obstruction due to goitre: detection, prevalence and results of surgical management. Q J Med 1990; 74:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32742/abstract/4\">",
"      Hedayati N, McHenry CR. The clinical presentation and operative management of nodular and diffuse substernal thyroid disease. Am Surg 2002; 68:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32742/abstract/5\">",
"      Newman E, Shaha AR. Substernal goiter. J Surg Oncol 1995; 60:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32742/abstract/6\">",
"      Erbil Y, Bozbora A, Barbaros U, et al. Surgical management of substernal goiters: clinical experience of 170 cases. Surg Today 2004; 34:732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32742/abstract/7\">",
"      Gittoes NJ, Miller MR, Daykin J, et al. Upper airways obstruction in 153 consecutive patients presenting with thyroid enlargement. BMJ 1996; 312:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32742/abstract/8\">",
"      Pieracci FM, Fahey TJ 3rd. Substernal thyroidectomy is associated with increased morbidity and mortality as compared with conventional cervical thyroidectomy. J Am Coll Surg 2007; 205:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32742/abstract/9\">",
"      White ML, Doherty GM, Gauger PG. Evidence-based surgical management of substernal goiter. World J Surg 2008; 32:1285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32742/abstract/10\">",
"      R&iacute;os A, Rodr&iacute;guez JM, Canteras M, et al. Surgical management of multinodular goiter with compression symptoms. Arch Surg 2005; 140:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32742/abstract/11\">",
"      Sancho JJ, Kraimps JL, Sanchez-Blanco JM, et al. Increased mortality and morbidity associated with thyroidectomy for intrathoracic goiters reaching the carina tracheae. Arch Surg 2006; 141:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32742/abstract/12\">",
"      Testini M, Gurrado A, Avenia N, et al. Does mediastinal extension of the goiter increase morbidity of total thyroidectomy? A multicenter study of 19,662 patients. Ann Surg Oncol 2011; 18:2251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32742/abstract/13\">",
"      de Perrot M, Fadel E, Mercier O, et al. Surgical management of mediastinal goiters: when is a sternotomy required? Thorac Cardiovasc Surg 2007; 55:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32742/abstract/14\">",
"      Pieracci FM, Fahey TJ 3rd. Effect of hospital volume of thyroidectomies on outcomes following substernal thyroidectomy. World J Surg 2008; 32:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32742/abstract/15\">",
"      Zambudio AR, Rodr&iacute;guez J, Riquelme J, et al. Prospective study of postoperative complications after total thyroidectomy for multinodular goiters by surgeons with experience in endocrine surgery. Ann Surg 2004; 240:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32742/abstract/16\">",
"      Shen WT, Kebebew E, Duh QY, Clark OH. Predictors of airway complications after thyroidectomy for substernal goiter. Arch Surg 2004; 139:656.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32742/abstract/17\">",
"      Berghout A, Wiersinga WM, Drexhage HA, et al. Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goitre. Lancet 1990; 336:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32742/abstract/18\">",
"      Shimaoka K, Sokal JE. Suppressive therapy of nontoxic goiter. Am J Med 1974; 57:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32742/abstract/19\">",
"      Anderson PE, Hurley PR, Rosswick P. Conservative treatment and long term prophylactic thyroxine in the prevention of recurrence of multinodular goiter. Surg Gynecol Obstet 1990; 171:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32742/abstract/20\">",
"      R&ouml;jdmark J, J&auml;rhult J. High long term recurrence rate after subtotal thyroidectomy for nodular goitre. Eur J Surg 1995; 161:725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32742/abstract/21\">",
"      Kay TW, d'Emden MC, Andrews JT, Martin FI. Treatment of non-toxic multinodular goiter with radioactive iodine. Am J Med 1988; 84:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32742/abstract/22\">",
"      Huysmans DA, Hermus AR, Corstens FH, et al. Large, compressive goiters treated with radioiodine. Ann Intern Med 1994; 121:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32742/abstract/23\">",
"      Bonnema SJ, Knudsen DU, Bertelsen H, et al. Does radioiodine therapy have an equal effect on substernal and cervical goiter volumes? Evaluation by magnetic resonance imaging. Thyroid 2002; 12:313.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7820 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.131.240.2-23F828356C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_62_32742=[""].join("\n");
var outline_f31_62_32742=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ANATOMIC RELATIONSHIPS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      SURGERY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Preoperative assessment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Surgical approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Recurrent laryngeal nerve injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Hypocalcemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Tracheomalacia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      LEVOTHYROXINE SUPPRESSION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      RADIOIODINE THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Recombinant human TSH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/7820\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7820|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?10/49/11026\" title=\"diagnostic image 1A\">",
"      Substernal goiter CT I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?21/16/21761\" title=\"diagnostic image 1B\">",
"      Substernal goiter CT II",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7820|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?34/40/35471\" title=\"figure 1\">",
"      Anatomy of thoracic inlet",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7820|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?28/57/29596\" title=\"table 1\">",
"      Management of hypocalcemia after thyroid surgery",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/2/46?source=related_link\">",
"      Clinical manifestations and evaluation of obstructive or substernal goiter",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/27/32185?source=related_link\">",
"      Diagnostic approach to and treatment of goiter in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/8/12424?source=related_link\">",
"      Surgery in the treatment of hyperthyroidism: Indications, preoperative preparation, and postoperative follow-up",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/17/44310?source=related_link\">",
"      Surgical anatomy of the thyroid gland",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/6/41064?source=related_link\">",
"      Surgical treatment of differentiated thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/0/22535?source=related_link\">",
"      Thyroid hormone suppressive therapy for thyroid nodules and benign goiter",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_62_32743="External otitis: Pathogenesis, clinical features, and diagnosis";
var content_f31_62_32743=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   External otitis: Pathogenesis, clinical features, and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/62/32743/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/62/32743/contributors\">",
"     Laura A Goguen, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/62/32743/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/62/32743/contributors\">",
"     Daniel G Deschler, MD, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/62/32743/contributors\">",
"     Ellen M Friedman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/62/32743/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/62/32743/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/62/32743/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/62/32743/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 8, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term external otitis (also known as otitis externa or swimmer&rsquo;s ear) refers to inflammation of the external auditory canal. Infectious, allergic, and dermatologic disease may all lead to external otitis. Acute bacterial infection is the most common cause of external otitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32743/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will focus on the pathogenesis, clinical features, and diagnosis of external otitis. The treatment of external otitis is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/10/12456?source=see_link\">",
"     \"External otitis: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H915662417\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;External otitis can occur in all age groups [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32743/abstract/2\">",
"     2",
"    </a>",
"    ]. An estimated 10 percent of people develop external otitis during their lifetime. Annual rates of ambulatory care visits in the United States for external otitis are highest during childhood and decrease with age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32743/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      7 percent ages 0 to 4 years",
"     </li>",
"     <li>",
"      19 percent ages 5 to 9 years",
"     </li>",
"     <li>",
"      16 percent ages 10 to 14 years",
"     </li>",
"     <li>",
"      9 percent ages 15 to 19 years",
"     </li>",
"     <li>",
"      5 percent ages &ge;20 years",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    External otitis is more likely to occur in the summer, compared to winter months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32743/abstract/2\">",
"     2",
"    </a>",
"    ]. This may be related to increased ambient humidity and participation in outdoor water activities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The external auditory canal is a cylinder measuring approximately 2.5 cm in length and 7.0 to 9.0 mm in width, extending from the conchal cartilage of the auricle to the tympanic membrane (",
"    <a class=\"graphic graphic_figure graphicRef57082 \" href=\"mobipreview.htm?33/19/34103\">",
"     figure 1",
"    </a>",
"    ). It is divided into a lateral (outer) cartilaginous portion that occupies approximately one-third of the canal and a medial (inner) bony portion that occupies the remaining two-thirds. Their junction is termed the isthmus and is the narrowest region of the ear canal. The outer cartilaginous portion is lined by thicker skin with numerous adnexal structures including cerumen glands, sebaceous glands, and hair follicles. The inner bony portion of the canal contains thin skin without subcutaneous tissue. The dermis in this area is in direct contact with the underlying periosteum. Thus, minimal inflammation or instrumentation of the bony canal causes significant pain",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    injury.",
"   </p>",
"   <p>",
"    The inferior tympanic recess is a small depression in the inferior medial aspect of the ear canal, adjacent to the tympanic membrane. Debris can collect in this area and cause or perpetuate infection.",
"   </p>",
"   <p>",
"    The lining of the ear canal is a keratinizing squamous epithelium that undergoes continual sloughing. Epithelial migration is a naturally occurring cleaning process for the ear canal that allows egress of keratin debris and cerumen. Epithelial migration begins in the center of the tympanic membrane and continues out to the medial, then lateral aspects of the ear canal.",
"   </p>",
"   <p>",
"    The ear canal is bound superiorly by the middle cranial fossa, anteriorly by the temporomandibular joint and parotid region, medially by the tympanic membrane, posteriorly by the mastoid cavity, and inferiorly by the skull base and soft tissues of the neck. These boundaries have particular importance when considering the potential complications of external otitis.",
"   </p>",
"   <p>",
"    The fissures of Santorini are a series of embryologic fissures in the anterior aspect of the cartilaginous portion of the canal through which neurovascular tissues pass. These fissures also allow potential spread of ear canal disease to the parotid region, temporomandibular joint, and soft tissue of the upper neck.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS AND RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several factors may contribute to the development of external otitis, despite the defense mechanisms of the auditory canal.",
"   </p>",
"   <p>",
"    The inherent defense mechanisms of the ear canal include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The tragus and conchal cartilage partially cover the opening of the ear canal and help to prevent foreign body entrance.",
"     </li>",
"     <li>",
"      Hair follicles and the isthmus narrowing inhibit entry of contaminants into the ear canal.",
"     </li>",
"     <li>",
"      Cerumen helps create an acidic ear canal environment, which inhibits bacterial and fungal growth. It is also hydrophobic, repelling water that might otherwise create an ideal culture medium. In addition, the sticky quality of cerumen helps to trap fine debris.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Breakdown of the skin-cerumen barrier is the first step in the pathogenesis of external otitis. Inflammation and edema of the skin then leads to pruritus and obstruction. The pruritus prompts scratching that may create further injury. This sequence of events alters the quality and amount of cerumen produced, impairs epithelial migration, and increases the pH of the ear canal. The resulting dark, warm, alkaline, moist ear canal becomes an ideal breeding ground for numerous organisms.",
"   </p>",
"   <p>",
"    Specific factors increase the risk of external otitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32743/abstract/4-7\">",
"     4-7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Swimming or other water exposure is a well-documented risk factor for external otitis. Excess moisture leads to skin maceration and breakdown of the skin-cerumen barrier, changing the microflora of the ear canal to predominantly gram-negative bacteria. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Microbiology'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Any trauma such as from excessive cleaning or aggressive scratching of the ear canal not only removes cerumen, but can also create abrasions along the thin layer of skin in the ear canal, allowing organisms to gain access to deeper tissue. In addition, part of a cotton swab may become detached or a small piece of tissue paper may be left behind in the ear canal; these remnants can partially disintegrate and fester, causing a severe skin reaction and infection.",
"     </li>",
"     <li>",
"      Devices that occlude the ear canal such as hearing aids, earphones, or diving caps can predispose to external otitis.",
"     </li>",
"     <li>",
"      Allergic contact dermatitis can lead to external otitis (eg, from earrings or chemicals in cosmetics or shampoos).",
"     </li>",
"     <li>",
"      Dermatologic conditions can also predispose to external otitis (eg, psoriasis, atopic dermatitis).",
"     </li>",
"     <li>",
"      Prior radiation therapy can cause ischemic ear canal changes, alter cerumen production and epithelial migration, and predispose to external otitis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ear canal is normally colonized with a number of aerobic and anaerobic bacteria, with more than 90 percent gram positive organisms (",
"    <a class=\"graphic graphic_table graphicRef69985 \" href=\"mobipreview.htm?20/43/21179\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32743/abstract/8\">",
"     8",
"    </a>",
"    ]. Staphylococci are the most common bacteria (63 percent) to inhabit the external ear, with S. auricularis (22 percent) and S. epidermidis (15 percent) being the most common species.",
"   </p>",
"   <p>",
"    The most common pathogenic organisms responsible for external otitis are P. aeruginosa (38 percent), S. epidermidis (9 percent), and S. aureus (8 percent) (",
"    <a class=\"graphic graphic_table graphicRef64716 graphicRef78637 \" href=\"mobipreview.htm?23/0/23565\">",
"     table 2A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32743/abstract/9\">",
"     9",
"    </a>",
"    ]. However, there are several other gram-positive and gram-negative bacteria that can also cause external otitis. Anaerobic pathogens are present in 4 to 25 percent of patients; bacteroides and peptostreptococci are the most frequently encountered anaerobic organisms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32743/abstract/5,9-11\">",
"     5,9-11",
"    </a>",
"    ]. Some patients may have mixed aerobic and anaerobic infection.",
"   </p>",
"   <p>",
"    Fungal infection accounts for two to ten percent of cases of external otitis, and most frequently occurs after treatment of bacterial infection. Candidal infection occurs more commonly in patients who use hearing aids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32743/abstract/12\">",
"     12",
"    </a>",
"    ]. Polymicrobial disease occurs in up to one-third of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32743/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Otomycosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H277540\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common symptoms of external otitis are ear pain, pruritus, discharge, and hearing loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32743/abstract/2\">",
"     2",
"    </a>",
"    ]. In addition to symptoms, patients should be asked about any known tympanic membrane perforation, previous ear infections, any prior ear surgery, recent ear instrumentation, and water exposure.",
"   </p>",
"   <p>",
"    On physical examination, the auricle and tragus should be examined for erythema or signs of trauma (",
"    <a class=\"graphic graphic_figure graphicRef57082 \" href=\"mobipreview.htm?33/19/34103\">",
"     figure 1",
"    </a>",
"    ). Tenderness with tragal pressure or when the auricle is manipulated or pulled are indicative findings of external otitis. However, these signs may be absent in mild cases.",
"   </p>",
"   <p>",
"    Otoscopy is critical for distinguishing between external otitis, otitis media, and other ear pathology. The ear canal usually appears edematous and erythematous in external otitis. Debris or cerumen is typically yellow, brown, white, or gray. Otomycosis, a fungal infection of the external canal, may take on different appearances (eg, fine, dark coating with Aspergillus; white, sebaceous-like material with Candida). (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Otomycosis'",
"    </a>",
"    below.) The tympanic membrane may be erythematous in external otitis and only partially visible due to canal edema. The presence of an air-fluid level along the tympanic membrane is indicative of a middle ear effusion and underlying otitis media (",
"    <a class=\"graphic graphic_picture graphicRef67379 \" href=\"mobipreview.htm?20/6/20576\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The examination is aided with a pneumatic otoscope that allows for insufflation (",
"    <a class=\"graphic graphic_picture graphicRef63633 \" href=\"mobipreview.htm?38/53/39774\">",
"     picture 2",
"    </a>",
"    ). The tympanic membrane in patients with external otitis should be mobile with pneumatic insufflation. With gentle application of positive then negative pressure by the pneumatic otoscope, the normal tympanic membrane moves inwards then outwards, respectively (",
"    <a class=\"graphic graphic_movie graphicRef55117 \" href=\"mobipreview.htm?34/4/34895\">",
"     movie 1",
"    </a>",
"    ). The movement of the tympanic membrane is most evident posterosuperiorly. A fluid-filled middle ear will minimize any tympanic membrane excursions with insufflation (",
"    <a class=\"graphic graphic_movie graphicRef67928 \" href=\"mobipreview.htm?21/56/22415\">",
"     movie 2",
"    </a>",
"    ). There should be no evidence of middle ear fluid in isolated external otitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/35/8760?source=see_link\">",
"     \"Acute otitis media in children: Diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/62/39913?source=see_link&amp;anchor=H16#H16\">",
"     \"Acute otitis media in adults (suppurative and serous)\", section on 'Diagnosis of AOM'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis of external otitis should also be questioned when the patient has a perforated tympanic membrane. It is likely that the primary focus of disease in these patients is the middle ear, with secondary inflammation of the ear canal. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/29/5593?source=see_link\">",
"     \"Evaluation and management of middle ear trauma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/47/13050?source=see_link&amp;anchor=H22#H22\">",
"     \"Evaluation of earache in children\", section on 'Traumatic tympanic membrane (TM) perforation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/62/39913?source=see_link&amp;anchor=H21#H21\">",
"     \"Acute otitis media in adults (suppurative and serous)\", section on 'Ruptured tympanic membrane'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The patient should be evaluated for deep tissue infection that might indicate malignant external otitis. Granulation tissue at the bony cartilaginous junction of the ear canal floor is a classic finding. Frank necrosis of ear canal skin may be evident. (See",
"    <a class=\"local\" href=\"#H277656\">",
"     'Malignant external otitis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H277602\">",
"    <span class=\"h2\">",
"     Severity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The spectrum of external otitis ranges from mild to severe, based upon the presenting symptoms and physical examination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32743/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mild disease is characterized by minor discomfort and pruritus (",
"      <a class=\"graphic graphic_picture graphicRef83227 \" href=\"mobipreview.htm?19/55/20337\">",
"       picture 3",
"      </a>",
"      ). There is minimal canal edema.",
"     </li>",
"     <li>",
"      Moderate disease is characterized by an intermediate degree of pain and pruritus. The canal is partially occluded (",
"      <a class=\"graphic graphic_picture graphicRef83228 \" href=\"mobipreview.htm?0/21/337\">",
"       picture 4",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Severe disease is characterized by intense pain, and the canal is completely occluded from edema. There is usually periauricular erythema, lymphadenopathy, and fever (",
"      <a class=\"graphic graphic_picture graphicRef55712 \" href=\"mobipreview.htm?43/29/44511\">",
"       picture 5",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H191116177\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of external otitis is clinical, based upon a characteristic history and physical examination. (See",
"    <a class=\"local\" href=\"#H277540\">",
"     'Clinical features'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H658697211\">",
"    <span class=\"h2\">",
"     Cultures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cultures are generally reserved for patients with severe cases of external otitis. Performing culture is usually more costly than simply starting empiric treatment, as some cases may not be infectious and many antibiotics cover the spectrum of the most common pathogens in external otitis. Thus, patients with mild and moderate external otitis do not need culture of the ear canal prior to starting therapy. However, cultures should be performed in those with severe external otitis, immunosuppressed patients (eg, post-transplant, HIV, receiving chemotherapy or radiation therapy), and patients who do not respond to initial therapy. Culture is performed using a small cotton swab within the external canal. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/10/12456?source=see_link&amp;anchor=H13312469#H13312469\">",
"     \"External otitis: Treatment\", section on 'Follow-up'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of disorders can mimic acute bacterial external otitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Otomycosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Otomycosis is a fungal infection of the external auditory canal. Otomycosis can occur as the primary infection or can develop along with bacterial external otitis, usually as a result of antibiotic therapy. Fungal infections are responsible for approximately 9 percent of outer ear infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32743/abstract/13\">",
"     13",
"    </a>",
"    ]. Aspergillus niger and Candida are the most common organisms, although the dominant organism varies according to geographic location. The incidence of otomycosis is higher in tropical and subtropical locations, probably because of the humidity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32743/abstract/14\">",
"     14",
"    </a>",
"    ]. Swimming and ear canal scratching or cleaning also predispose to otomycosis. Concern has been raised that excessive use of antibiotic ear drops might allow fungal proliferation. However, the incidence and types of fungal infections have not changed significantly despite several decades of topical antibiotic use.",
"   </p>",
"   <p>",
"    Patients with otomycosis most commonly report ear itching, discomfort, discharge,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a feeling that something is in the ear canal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32743/abstract/15\">",
"     15",
"    </a>",
"    ]. Deep seated itching is the most troublesome symptom; pain is less intense than with bacterial external otitis.",
"   </p>",
"   <p>",
"    Fungal infections are often located in the medial aspect of the ear canal. This may be due in part to the location of the inferior tympanic recess (",
"    <a class=\"graphic graphic_figure graphicRef57082 \" href=\"mobipreview.htm?33/19/34103\">",
"     figure 1",
"    </a>",
"    ), which facilitates accumulation of debris in this area. In addition, the medial aspect of the ear canal is darker and warmer, features that promote fungal growth.",
"   </p>",
"   <p>",
"    Edema of the ear canal is less severe than with bacterial external otitis. Fungal organisms have a very characteristic appearance in the ear canal, especially under magnified vision (",
"    <a class=\"graphic graphic_picture graphicRef83226 \" href=\"mobipreview.htm?13/26/13732\">",
"     picture 6",
"    </a>",
"    ). Fine fungal filaments and spores may be seen that resemble mold growing on spoiled food. Aspergillus niger spores look like a fine coal dust sprinkled in the ear canal. Aspergillus may also resemble wet newspaper or blotting paper. Candidal infections typically are associated with soft, white, sebaceous-like material that may fill the ear canal in severe cases. A pseudomembrane often lines the ear canal that, when removed, reveals an underlying friable granular membrane.",
"   </p>",
"   <p>",
"    The treatment of otomycosis is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/10/12456?source=see_link&amp;anchor=H569884918#H569884918\">",
"     \"External otitis: Treatment\", section on 'Otomycosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Contact dermatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with persistent edema and erythema of the ear canal and auricle despite appropriate external otitis treatment may be experiencing an allergic reaction. Contact dermatitis can be commonly caused by ototopical medication, cosmetics, or shampoos. These are Gell and Coombs type IV delayed hypersensitivity reactions; secondary exposure to the allergen initiates an inflammatory response.",
"   </p>",
"   <p>",
"    Contact dermatitis should be considered if there has been a lack of response to external otitis treatment over a one week period. Pruritus is the dominant symptom. Erythema intensifies and classically extends to the inferior aspect of the conchal cartilage where drops often collect after application (",
"    <a class=\"graphic graphic_picture graphicRef70837 \" href=\"mobipreview.htm?6/26/6560\">",
"     picture 7",
"    </a>",
"    ). Vesicles may be seen, and there are often extensive secondary changes from rubbing and itching.",
"   </p>",
"   <p>",
"    Common ototopical agents causing allergic reactions are",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/57/14229?source=see_link\">",
"     neomycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/7/6264?source=see_link\">",
"     benzocaine",
"    </a>",
"    , and propylene glycol [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32743/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?13/57/14229?source=see_link\">",
"       Neomycin",
"      </a>",
"      allergy occurs in 35 percent of chronically treated patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32743/abstract/18\">",
"       18",
"      </a>",
"      ]. Cross reactivity among other aminoglycosides, including",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?33/35/34352?source=see_link\">",
"       tobramycin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/10/36000?source=see_link\">",
"       gentamicin",
"      </a>",
"      , is common.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?6/7/6264?source=see_link\">",
"       Benzocaine",
"      </a>",
"      is the topical anesthetic present in many ototopical anesthetic otic solutions (eg, Auralgan, Americaine, Tympanagesic). It is an allergic sensitizer, particularly in the presence of skin breakdown. Pain from external otitis should be managed with oral nonsteroidal anti-inflammatory agents or mild opioids to avoid sensitization by topical anesthetics. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/62/34792?source=see_link&amp;anchor=H3#H3\">",
"       \"Allergic reactions to local anesthetics\", section on 'Contact dermatitis or delayed local swelling'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Propylene glycol is a common solvent and preservative in ototopical agents. It can act as a primary irritant or an allergic sensitizer.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If the causative agent is not readily apparent by history alone, patch testing can help identify the allergen.",
"   </p>",
"   <p>",
"    The treatment of contact dermatitis of the ear canal is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/10/12456?source=see_link&amp;anchor=H569884925#H569884925\">",
"     \"External otitis: Treatment\", section on 'Contact dermatitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Chronic suppurative otitis media",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with chronic suppurative otitis media (CSOM) may also present with a draining ear and can be mistakenly thought to have external otitis. CSOM is usually associated with a long history of ear disease. Symptoms of CSOM include otorrhea and possibly otalgia, hearing loss, tinnitus, or vertigo. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/26/1450?source=see_link&amp;anchor=H98017535#H98017535\">",
"     \"Chronic otitis media, cholesteatoma, and mastoiditis in adults\", section on 'Chronic suppurative otitis media'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Ear canal symptoms and signs are usually mild compared with acute bacterial external otitis. Swelling typically does not completely occlude the canal. Ear canal findings are focused medially near the tympanic membrane where polyps or granulation tissue may be seen. The tympanic membrane is usually at least partly visible and frequently not mobile on insufflation. A tympanic membrane perforation or retraction pocket may be evident. The pocket can be filled with white, cheesy-looking, keratin debris consistent with a cholesteatoma (",
"    <a class=\"graphic graphic_picture graphicRef55060 \" href=\"mobipreview.htm?24/52/25423\">",
"     picture 8",
"    </a>",
"    ). Patients with these findings should be referred to an otolaryngologist. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/26/1450?source=see_link&amp;anchor=H98017535#H98017535\">",
"     \"Chronic otitis media, cholesteatoma, and mastoiditis in adults\", section on 'Chronic suppurative otitis media'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/62/39913?source=see_link&amp;anchor=H21#H21\">",
"     \"Acute otitis media in adults (suppurative and serous)\", section on 'Ruptured tympanic membrane'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/0/21514?source=see_link\">",
"     \"Acute otitis media in children: Treatment\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Carcinoma of the ear canal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cancer of the external auditory canal is a rare disease that should always be considered any time there is an abnormal tissue growth in the ear canal or a lack of response to prolonged external otitis treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32743/abstract/19\">",
"     19",
"    </a>",
"    ]. Ear canal cancer occurs far less frequently than auricular cancer. In the early stages it is often indistinguishable from external otitis. The diagnosis of carcinoma of the external auditory canal is often delayed secondary to misdiagnosis as external otitis.",
"   </p>",
"   <p>",
"    Mild pain and bloody otorrhea are common symptoms. A friable ear canal lesion with surrounding purulence is a typical finding on otoscopy. Hearing loss and facial paralysis may develop as late signs. The definitive diagnosis is made with biopsy of the lesion or affected area.",
"   </p>",
"   <p>",
"    The treatment of ear canal carcinoma is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/10/12456?source=see_link&amp;anchor=H63949079#H63949079\">",
"     \"External otitis: Treatment\", section on 'Carcinoma of the ear canal'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Psoriasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psoriasis can commonly involve the external ear canal, causing redness and scaling. The clinical appearance of psoriasis in the external canal may vary. The diagnosis is aided by biopsy, which has classic histologic findings including epidermal hyperplasia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/62/27625?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of psoriasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H277695\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications of external otitis include periauricular cellulitis and malignant external otitis. Periauricular cellulitis presents with erythema, edema, and warmth of the skin around the auricle. Pain is generally mild and systemic manifestations are usually absent, which help distinguish cellulitis from malignant external otitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/33/12825?source=see_link&amp;anchor=H2#H2\">",
"     \"Cellulitis and erysipelas\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H277656\">",
"    <span class=\"h2\">",
"     Malignant external otitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malignant external otitis (also termed necrotizing external otitis) is a severe, potentially fatal complication of acute bacterial external otitis. Most common in elderly diabetic patients or other immunocompromised individuals, it occurs when the infection spreads from the skin to bone and marrow spaces of the skull base (also involving soft tissue and cartilage of the temporal region).",
"   </p>",
"   <p>",
"    Patients typically have severe otalgia and otorrhea with pain that appears out of proportion to examination findings. Granulation tissue at the bony cartilaginous junction of the ear canal floor is a classic finding. Edema, erythema, and frank necrosis of ear canal skin may be evident. Cranial nerve palsies are a poor prognostic sign. Patients generally have a markedly elevated erythrocyte sedimentation rate (ESR). Diagnosis is aided with an abnormal MRI or CT scan showing extension of infection into bony structures. Patients who may have malignant external otitis should be promptly referred to an otolaryngologist.",
"   </p>",
"   <p>",
"    Malignant external otitis is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/47/20216?source=see_link\">",
"     \"Malignant (necrotizing) external otitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?15/2/15394?source=see_link\">",
"       \"Patient information: Outer ear infection (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?26/12/26816?source=see_link\">",
"       \"Patient information: External otitis (including swimmer's ear) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The term external otitis (also known as otitis externa or swimmer&rsquo;s ear) refers to inflammation of the external auditory canal or auricle, usually from infection.",
"     </li>",
"     <li>",
"      Risk factors for developing external otitis include swimming (or other water exposure), trauma (eg, ear scratching, cotton swabs), occlusive ear devices (eg, hearing aids, ear phones), allergic contact dermatitis (eg, due to shampoos, cosmetics), and dermatologic conditions (eg, psoriasis). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathogenesis and risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      External otitis usually presents with ear pain, pruritus, and discharge. Examination findings of external otitis include tenderness when the tragus is pushed or the auricle is pulled, as well as erythema and swelling of the external auditory canal. The otoscopic examination should also assess for otitis media, tympanic membrane perforation, and signs of other disease. (See",
"      <a class=\"local\" href=\"#H277540\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      External otitis is categorized by severity as mild, moderate, or severe (see",
"      <a class=\"local\" href=\"#H277602\">",
"       'Severity'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Mild disease is characterized by pruritus, minor discomfort, and minimal canal edema (",
"      <a class=\"graphic graphic_picture graphicRef83227 \" href=\"mobipreview.htm?19/55/20337\">",
"       picture 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Moderate disease is characterized by pruritus, an intermediate degree of pain, and a partially-occluded canal (",
"      <a class=\"graphic graphic_picture graphicRef83228 \" href=\"mobipreview.htm?0/21/337\">",
"       picture 4",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Severe disease is characterized by complete canal obstruction, intense pain, periauricular erythema, adenopathy, and fever (",
"      <a class=\"graphic graphic_picture graphicRef55712 \" href=\"mobipreview.htm?43/29/44511\">",
"       picture 5",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnosis of external otitis is clinical, based upon a characteristic history and physical examination. Cultures are reserved for patients with severe external otitis, immunocompromised patients, as well as those who do not respond to initial therapy. (See",
"      <a class=\"local\" href=\"#H191116177\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis for external otitis includes otomycosis, contact dermatitis, chronic suppurative otitis media, and ear canal carcinoma. Carcinoma of the ear canal is a rare, aggressive disease that is suggested by blood otorrhea, a friable ear canal, and failure to respond to treatment for external otitis. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Malignant (necrotizing) external otitis occurs when external otitis spreads to the skull base (soft tissue, cartilage, and bone of the temporal region and skull). Malignant external otitis most commonly develops in elderly diabetic patients or other immunocompromised individuals. Severe pain, otorrhea, presence of granulation tissue in the canal floor, and cranial nerve palsies may be present. These patients should be promptly referred to an otolaryngologist. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/47/20216?source=see_link\">",
"       \"Malignant (necrotizing) external otitis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32743/abstract/1\">",
"      Stone KE. Otitis externa. Pediatr Rev 2007; 28:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32743/abstract/2\">",
"      Beers SL, Abramo TJ. Otitis externa review. Pediatr Emerg Care 2004; 20:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32743/abstract/3\">",
"      Centers for Disease Control and Prevention (CDC). Estimated burden of acute otitis externa--United States, 2003-2007. MMWR Morb Mortal Wkly Rep 2011; 60:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32743/abstract/4\">",
"      Agius AM, Pickles JM, Burch KL. A prospective study of otitis externa. Clin Otolaryngol Allied Sci 1992; 17:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32743/abstract/5\">",
"      Russell JD, Donnelly M, McShane DP, et al. What causes acute otitis externa? J Laryngol Otol 1993; 107:898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32743/abstract/6\">",
"      van Asperen IA, de Rover CM, Schijven JF, et al. Risk of otitis externa after swimming in recreational fresh water lakes containing Pseudomonas aeruginosa. BMJ 1995; 311:1407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32743/abstract/7\">",
"      Osguthorpe JD, Nielsen DR. Otitis externa: Review and clinical update. Am Fam Physician 2006; 74:1510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32743/abstract/8\">",
"      Stroman DW, Roland PS, Dohar J, Burt W. Microbiology of normal external auditory canal. Laryngoscope 2001; 111:2054.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32743/abstract/9\">",
"      Roland PS, Stroman DW. Microbiology of acute otitis externa. Laryngoscope 2002; 112:1166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32743/abstract/10\">",
"      Brook I, Frazier EH, Thompson DH. Aerobic and anaerobic microbiology of external otitis. Clin Infect Dis 1992; 15:955.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32743/abstract/11\">",
"      Clark WB, Brook I, Bianki D, Thompson DH. Microbiology of otitis externa. Otolaryngol Head Neck Surg 1997; 116:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32743/abstract/12\">",
"      Ahmad N, Etheridge C, Farrington M, Baguley DM. Prospective study of the microbiological flora of hearing aid moulds and the efficacy of current cleaning techniques. J Laryngol Otol 2007; 121:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32743/abstract/13\">",
"      Munguia R, Daniel SJ. Ototopical antifungals and otomycosis: a review. Int J Pediatr Otorhinolaryngol 2008; 72:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32743/abstract/14\">",
"      Vennewald I, Klemm E. Otomycosis: Diagnosis and treatment. Clin Dermatol 2010; 28:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32743/abstract/15\">",
"      Ho T, Vrabec JT, Yoo D, Coker NJ. Otomycosis: clinical features and treatment implications. Otolaryngol Head Neck Surg 2006; 135:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32743/abstract/16\">",
"      Gehrig KA, Warshaw EM. Allergic contact dermatitis to topical antibiotics: Epidemiology, responsible allergens, and management. J Am Acad Dermatol 2008; 58:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32743/abstract/17\">",
"      Sood S, Strachan DR, Tsikoudas A, Stables GI. Allergic otitis externa. Clin Otolaryngol Allied Sci 2002; 27:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32743/abstract/18\">",
"      Van Ginkel CJ, Bruintjes TD, Huizing EH. Allergy due to topical medications in chronic otitis externa and chronic otitis media. Clin Otolaryngol Allied Sci 1995; 20:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32743/abstract/19\">",
"      Magliulo G, Ciniglio Appiani M. Mucoepidermoid carcinoma of the external auditory canal. Otolaryngol Head Neck Surg 2010; 142:624.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6866 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-806F72AFFC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_62_32743=[""].join("\n");
var outline_f31_62_32743=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H29\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H915662417\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS AND RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H277540\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H277602\">",
"      Severity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H191116177\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H658697211\">",
"      Cultures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Otomycosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Contact dermatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Chronic suppurative otitis media",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Carcinoma of the ear canal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Psoriasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H277695\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H277656\">",
"      Malignant external otitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/6866\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6866|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?33/19/34103\" title=\"figure 1\">",
"      External ear anatomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6866|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?20/6/20576\" title=\"picture 1\">",
"      TM air fluid level",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?38/53/39774\" title=\"picture 2\">",
"      Pneumatic otoscope",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?19/55/20337\" title=\"picture 3\">",
"      Mild OE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?0/21/337\" title=\"picture 4\">",
"      Moderate OE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?43/29/44511\" title=\"picture 5\">",
"      Severe otitis externa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?13/26/13732\" title=\"picture 6\">",
"      Fungal OE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?6/26/6560\" title=\"picture 7\">",
"      Contact dermatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?24/52/25423\" title=\"picture 8\">",
"      Cholesteatoma tympanic membrane",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6866|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?34/4/34895\" title=\"movie 1\">",
"      Normal TM mobility",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?21/56/22415\" title=\"movie 2\">",
"      Impaired TM mobility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6866|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?20/43/21179\" title=\"table 1\">",
"      Ear canal normal flora",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?24/29/25052\" title=\"table 2A\">",
"      External otitis microbiology A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?6/30/6636\" title=\"table 2B\">",
"      External otitis microbiology B",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/62/39913?source=related_link\">",
"      Acute otitis media in adults (suppurative and serous)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/35/8760?source=related_link\">",
"      Acute otitis media in children: Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/0/21514?source=related_link\">",
"      Acute otitis media in children: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/62/34792?source=related_link\">",
"      Allergic reactions to local anesthetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/33/12825?source=related_link\">",
"      Cellulitis and erysipelas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/26/1450?source=related_link\">",
"      Chronic otitis media, cholesteatoma, and mastoiditis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/62/27625?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of psoriasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/29/5593?source=related_link\">",
"      Evaluation and management of middle ear trauma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/47/13050?source=related_link\">",
"      Evaluation of earache in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/10/12456?source=related_link\">",
"      External otitis: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/47/20216?source=related_link\">",
"      Malignant (necrotizing) external otitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?26/12/26816?source=related_link\">",
"      Patient information: External otitis (including swimmer's ear) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?15/2/15394?source=related_link\">",
"      Patient information: Outer ear infection (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_62_32744="AIDS-related Kaposis sarcoma - gingiva";
var content_f31_62_32744=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F61561%7EDERM%2F50835&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F61561%7EDERM%2F50835&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    AIDS-related Kaposi's sarcoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Nodules of Kaposi's sarcoma are present on the gingiva.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    AIDS-related Kaposi's sarcoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Nodules of Kaposi's sarcoma are present on the palate.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_62_32744=[""].join("\n");
var outline_f31_62_32744=null;
var title_f31_62_32745="Lentigo maligna melanoma dermoscopy 1";
var content_f31_62_32745=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F63812%7EDERM%2F68828&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F63812%7EDERM%2F68828&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Dermoscopy of lentigo maligna melanoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 370px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A 69-year-old woman was evaluated for an enlarging pigmented lesion of her right cheek.&nbsp;Two biopsies were performed with the help of dermoscopy to outline the borders of the lesion. Pathology revealed a lentigo maligna melanoma. On this dermoscopic image (x50), one can see slate-gray dots and globules leading to annular-granular pattern which is typical of lentigo maligna melanoma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Eric Ehrsam, MD, Dermatlas;",
"     <a href=\"file://www.dermatlas.org\" target=\"_blank\">",
"      file://www.dermatlas.org",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Dermoscopic features of lentigo maligna",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Atypical pseudonetwork, annular-granular pattern and slate-gray areas are characteristics of lentigo maligna.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_62_32745=[""].join("\n");
var outline_f31_62_32745=null;
var title_f31_62_32746="Approach to the patient with colonic polyps";
var content_f31_62_32746=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to the patient with colonic polyps",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/62/32746/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/62/32746/contributors\">",
"     Dennis J Ahnen, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/62/32746/contributors\">",
"     Finlay A Macrae, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/62/32746/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/62/32746/contributors\">",
"     Paul Rutgeerts, MD, PhD, FRCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/62/32746/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/62/32746/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/62/32746/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 4, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A polyp of the colon refers to a protuberance into the lumen from the normally flat colonic mucosa. Polyps are usually asymptomatic but may ulcerate and bleed, cause tenesmus if in the rectum, and, when very large, produce intestinal obstruction. Colonic polyps are usually classified as non-neoplastic, hamartomatous, neoplastic (adenomas and carcinomas), serrated (which can be neoplastic or non-neoplastic), and submucosal (which can be neoplastic or non-neoplastic).",
"   </p>",
"   <p>",
"    The different types of benign polyps that develop sporadically and their management will be reviewed here. Colon cancer screening in the average risk individual, surveillance after colorectal cancer resection, and screening in individuals with colorectal polyposis syndromes are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/10/37034?source=see_link\">",
"     \"Screening for colorectal cancer: Strategies in patients at average risk\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/41/9881?source=see_link\">",
"     \"Screening for colorectal cancer: Strategies in patients with possible increased risk due to family history\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/61/28634?source=see_link\">",
"     \"Surveillance after colorectal cancer resection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/39/17016?source=see_link\">",
"     \"Clinical manifestations and diagnosis of familial adenomatous polyposis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/6/37990?source=see_link\">",
"     \"Overview of Peutz-Jeghers syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     NON-NEOPLASTIC POLYPS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The non-neoplastic colonic polyps may be grouped into several distinct categories:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hyperplastic",
"     </li>",
"     <li>",
"      Mucosal",
"     </li>",
"     <li>",
"      Inflammatory pseudopolyps",
"     </li>",
"     <li>",
"      Submucosal, some of which may be neoplastic (eg, lipomatous, leiomyoma)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26829073\">",
"    <span class=\"h2\">",
"     Hyperplastic polyps",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperplastic polyps are the most common polyps traditionally included in the non-neoplastic category. Because of evidence suggesting that these polyps are part of the larger group of polyps known as serrated polyps and because some hyperplastic polyps appear to progress to more advanced lesions and cancer, we have included them in the section on serrated polyps below. (See",
"    <a class=\"local\" href=\"#H26827993\">",
"     'Hyperplastic polyps'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Mucosal polyps",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mucosal polyps are small (usually &lt;5 mm) excrescences of tissue that endoscopically resemble the adjacent flat mucosa and histologically are normal mucosa. They have no clinical significance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Inflammatory pseudopolyps",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inflammatory pseudopolyps are irregularly shaped islands of residual intact colonic mucosa that are the result of the mucosal ulceration and regeneration that occurs in inflammatory bowel disease (IBD). These polyps are typically multiple, often filiform and scattered throughout the colitic region of the colon. They may also be more isolated and semipedunculated in areas of more active recent inflammation, and have mucus adherent to their apices (",
"    <a class=\"graphic graphic_picture graphicRef76729 \" href=\"mobipreview.htm?34/33/35358\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    When pseudopolyps are in clusters, they may be associated with surrounding dysplasia, and, in this circumstance, careful attention to biopsy of the region is important. However, their presence complicates the use of surveillance colonoscopy strategies in patients with IBD, not least because the larger, inflamed polyps are quite vascular. When typical, they are best left in situ. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/7/11386?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and prognosis of ulcerative colitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Submucosal polyps",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of submucosal lesions including lymphoid aggregates, lipomas, leiomyomas, pneumatosis cystoid intestinalis, hemangiomas, fibromas, carcinoids, and metastatic lesions may impart a polypoid appearance to the overlying mucosa. The most common of these, the lipoma, can be diagnosed endoscopically because of its yellow color and softness, assessed by probing the polyp with forceps and eliciting the \"pillow sign\" of indentation on gentle pressure. Endoscopic ultrasound can be useful in defining the site of origin and for biopsy of submucosal lesions if the diagnosis is in doubt. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/13/1242?source=see_link\">",
"     \"Endoscopic ultrasound for the characterization of subepithelial lesions of the upper gastrointestinal tract\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15416963\">",
"    <span class=\"h2\">",
"     Hamartomatous polyps",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hamartomatous polyps are polyps that are made up of tissue elements normally found at that site, but which are growing in a disorganized mass. Hamartomatous polyps have traditionally been classified as non-neoplastic but some hamartomatous polyps develop dysplasia and lead to colorectal cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15416970\">",
"    <span class=\"h3\">",
"     Juvenile polyps",
"    </span>",
"    &nbsp;&mdash;&nbsp;Juvenile polyps are hamartomatous lesions that consist of a lamina propria and dilated cystic glands rather than increased numbers of epithelial cells (",
"    <a class=\"graphic graphic_picture graphicRef72376 \" href=\"mobipreview.htm?37/2/37928\">",
"     picture 2",
"    </a>",
"    ). They are usually removed because of a high likelihood of bleeding. Juvenile polyps can be diagnosed at any age, although they are relatively more common in childhood.",
"   </p>",
"   <p>",
"    Juvenile polyposis coli (JPC) is often defined as the occurrence of 10 or more juvenile polyps. Approximately one-third of cases of JPC have a history of similar lesions in at least one first-degree relative, and are called familial juvenile polyposis (FJP). A subset of juvenile polyposis families has germline mutations in the",
"    <em>",
"     SMAD4",
"    </em>",
"    gene on chromosome 18q21.1, or in the gene",
"    <em>",
"     BMPR1A",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"    <em>",
"     SMAD4",
"    </em>",
"    (also known as",
"    <em>",
"     DPC4",
"    </em>",
"    ) encodes a mediator in the transforming growth factor-beta signaling pathway. FJP is associated with an increased risk for the development of colorectal cancer and, in some families (most notably SMAD4 gene carriers), upper gastrointestinal hamartomatous polyps and gastric cancer. &nbsp;(See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/9/3224?source=see_link&amp;anchor=H21759704#H21759704\">",
"     \"Peutz-Jeghers syndrome and juvenile polyposis: Screening and management of patients and families\", section on 'Juvenile polyposis syndrome and familial juvenile polyposis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15416977\">",
"    <span class=\"h3\">",
"     Peutz-Jeghers polyps",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Peutz-Jeghers polyp is a hamartomatous lesion of glandular epithelium supported by smooth muscle cells that is contiguous with the muscularis mucosa (",
"    <a class=\"graphic graphic_picture graphicRef69268 \" href=\"mobipreview.htm?34/63/35833\">",
"     picture 3",
"    </a>",
"    ). It is almost always associated with the Peutz-Jeghers syndrome (PJS). The polyps are usually benign, but may grow progressively and produce symptoms or undergo malignant transformation. Patients with PJS are at increased risk of both gastrointestinal (gastric, small bowel, colon, pancreas) and nongastrointestinal cancers, especially including breast cancer and testicular cancer, with a cumulative overall cancer risk of about 50 percent by age 60. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/6/37990?source=see_link\">",
"     \"Overview of Peutz-Jeghers syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15416984\">",
"    <span class=\"h3\">",
"     Cronkhite-Canada syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cronkhite-Canada syndrome is a rare, nonfamilial disorder of unknown etiology associated with alopecia, cutaneous hyperpigmentation, gastrointestinal polyposis, onychodystrophy (",
"    <a class=\"graphic graphic_picture graphicRef76442 \" href=\"mobipreview.htm?7/50/7968\">",
"     picture 4",
"    </a>",
"    ), diarrhea, weight loss, and abdominal pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. The polyps are hamartomas and do not appear neoplastic pathologically. Characteristic features include myxoid expansion of the lamina propria and increased eosinophils in the polyps [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. There is some evidence that the disorder may be immune-mediated, since it may respond to immunosuppressive therapy and, in some patients, immunostaining of the polyps for IgG4 is positive [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/9\">",
"     9",
"    </a>",
"    ]. Five-year mortality rates as high as 55 percent have been reported with most deaths due to gastrointestinal bleeding, sepsis, and congestive heart failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/10\">",
"     10",
"    </a>",
"    ]. Treatment has included nutritional support, glucocorticoids,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    , acid suppression, and antibiotics, but no specific treatment has proven to be consistently effective [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/9,11,12\">",
"     9,11,12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5190142\">",
"    <span class=\"h2\">",
"     Perineuromas/fibroblastic polyps",
"    </span>",
"    &nbsp;&mdash;&nbsp;Perineuriomas are benign tumors comprised of perineurial cells and they occasionally present as colon polyps [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/13\">",
"     13",
"    </a>",
"    ]. Fibroblastic polyps have identical clinical and histologic features and some have suggested, based upon immunohistochemical staining, that they represent the same entities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. These polyps are believed to be benign and surveillance is not recommended. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/24/23946?source=see_link&amp;anchor=H30353444#H30353444\">",
"     \"Peripheral nerve tumors\", section on 'Perineurioma'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14623567\">",
"    <span class=\"h1\">",
"     NEOPLASTIC POLYPS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The common neoplastic colonic polyps include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Serrated polyps",
"     </li>",
"     <li>",
"      Adenomatous polyps",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26827803\">",
"    <span class=\"h2\">",
"     Serrated polyps",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serrated polyps are a heterogenous group of polyps with variable malignant potential. They include hyperplastic polyps, traditional serrated adenomas, and sessile serrated polyps (also known as sessile serrated adenomas) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26827993\">",
"    <span class=\"h3\">",
"     Hyperplastic polyps",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperplastic polyps are the most common non-neoplastic polyp in the colon. They are small nodules or polypoid lesions that may be indistinguishable grossly from adenomatous polyps (",
"    <a class=\"graphic graphic_picture graphicRef66254 \" href=\"mobipreview.htm?29/58/30628\">",
"     picture 5",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Histology &ndash; Hyperplastic polyps are composed of normal cellular components, do not exhibit dysplasia, and have a characteristic serrated (\"saw tooth\") pattern when seen sectioned along the crypt axis (",
"      <a class=\"graphic graphic_picture graphicRef59446 \" href=\"mobipreview.htm?38/16/39177\">",
"       picture 6",
"      </a>",
"      ). Proliferation is mainly in the basal portion of the crypt of hyperplastic polyps, a feature that can be assessed on H and E stains, which are used by pathologists to distinguish hyperplastic polyps from adenomas [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Location &ndash; They are typically located in the rectosigmoid and are less than 5 mm in size [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/18,19\">",
"       18,19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Risk of cancer &ndash; Distal small hyperplastic polyps rarely, if ever, develop into colorectal cancers.",
"     </li>",
"     <li>",
"      Surveillance &ndash; Patients with small (&le;10 mm) hyperplastic polyps confined to the rectum and sigmoid colon should be advised to undergo their next",
"      <span class=\"nowrap\">",
"       screening/surveillance",
"      </span>",
"      examination in 10 years. There are no data to directly support these screening intervals but these recommendations are based on evidence that small rectosigmoid hyperplastic polyps do not appear to increase the risk of colorectal cancer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/20\">",
"       20",
"      </a>",
"      ]. This surveillance approach is consistent with the 2012 update of the United States Multi-Society Task Force guidelines (",
"      <a class=\"graphic graphic_table graphicRef86494 \" href=\"mobipreview.htm?2/50/2861\">",
"       table 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Multiple studies have evaluated the risk of proximal neoplasms in patients found to have distal hyperplastic polyps [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/22-26\">",
"     22-26",
"    </a>",
"    ]. A systematic review that included 18 studies estimated that 21 to 25 percent of patients found to have a distal hyperplastic polyp had a proximal neoplasm (including 4 to 5 percent with an advanced neoplasm) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/25\">",
"     25",
"    </a>",
"    ]. In the four studies in which a colonoscopy was performed irrespective of distal findings, the relative risk of any proximal neoplasia (advanced or not) was 1.3 (95% CI 0.9 to 1.8). Thus, it is not clear that the risk of proximal neoplasia is elevated in this setting and, even if it is, the magnitude of risk appears to be small. The general consensus is that small left-sided hyperplastic polyps are not a significant marker of colon cancer risk and that finding them on a sigmoidoscopy is not a routine indication for colonoscopy.",
"   </p>",
"   <p>",
"    However, studies suggest that serrated lesions that are larger or proximal may be associated with an increased risk of conventional adenomas:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of 1371 patients who underwent screening colonoscopy with subsequent surveillance, patients with proximal nondysplastic serrated polyps were more likely to have synchronous advanced neoplasia than patients without proximal nondysplastic serrated polyps (17 versus 10 percent) and were more likely to have three or more small tubular adenomas detected (11 versus 5 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/27\">",
"       27",
"      </a>",
"      ]. The presence of a proximal or a large nondysplastic serrated polyp was associated with an increased risk of having metachronous adenomas during surveillance.",
"     </li>",
"     <li>",
"      In a study of 10,199 patients undergoing first-time colonoscopy, the presence of large (&ge;10 mm) serrated polyps was associated with an increased risk of synchronous advanced neoplasia (odds ratio 4.01), and colorectal cancer (odds ratio 2.16) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A limitation in generalizing these studies, however, is that they included not only hyperplastic polyps, but also sessile serrated polyps, and in the case of the second study, serrated adenomas (see",
"    <a class=\"local\" href=\"#H26828552\">",
"     'Sessile serrated adenoma/polyps and traditional serrated adenomas'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26828020\">",
"    <span class=\"h3\">",
"     Serrated polyposis syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serrated polyposis syndrome (also known as hyperplastic polyposis syndrome [HPS]) refers to a rare condition characterized by multiple, large",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    proximal hyperplastic polyps and, occasionally, smaller numbers of serrated adenomas, adenomas, or mixed",
"    <span class=\"nowrap\">",
"     hyperplastic/adenomatous",
"    </span>",
"    polyps [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H26828552\">",
"     'Sessile serrated adenoma/polyps and traditional serrated adenomas'",
"    </a>",
"    below.) The World Health Organization criteria for serrated polyposis syndrome require the presence of one or more of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      At least five serrated polyps proximal to the sigmoid colon, of which two or more are &ge;10 mm",
"     </li>",
"     <li>",
"      Any number of serrated polyps proximal to the sigmoid colon in an individual who has a first degree relative with serrated polyposis syndrome",
"     </li>",
"     <li>",
"      Greater than 20 serrated polyps of any size, distributed throughout the colon",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Polyps in serrated polyposis syndrome are characteristically large and flat and are typically found along the crests of haustral folds. Mucus and residue frequently adhere to the polyps, at times making it difficult to discriminate the polyp from the surrounding normal colonic mucosa.",
"   </p>",
"   <p>",
"    Unlike patients with sporadic small, distal hyperplastic polyps, patients with serrated polyposis syndrome appear to be at increased risk of colorectal cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Molecular studies have identified high levels of gene methylation of the polyps and the colonic mucosa with patterns of gene methylation that are uncommon, if not unique, to the syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/32\">",
"     32",
"    </a>",
"    ]. Cancers that occur in serrated polyposis syndrome typically follow a pathway characterized by hypermethylation of numerous genes (so-called CpG Island Methylator Phenotype [CIMP high]), and have activating BRAF mutations (",
"    <a class=\"graphic graphic_table graphicRef77353 \" href=\"mobipreview.htm?7/38/7788\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/33/30234?source=see_link\">",
"     \"Molecular genetics of colorectal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Serrated polyposis syndrome is the only remaining polyposis condition for which no germline mutation predisposing to the condition has been identified. It does not appear to have a strong association with mutations in the",
"    <em>",
"     MUTYH",
"    </em>",
"    or",
"    <em>",
"     MBD4",
"    </em>",
"    genes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/29\">",
"     29",
"    </a>",
"    ]. Patients sometimes have sufficient numbers of both hyperplastic and adenomatous polyps to qualify for the criteria for both attenuated familial adenomatous polyposis and hyperplastic polyposis, and in these cases a search for mutations in the",
"    <em>",
"     APC",
"    </em>",
"    gene and especially for",
"    <em>",
"     MUTYH",
"    </em>",
"    mutations is warranted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A family history of CRC has been reported in 33 to 59 percent of patients with hyperplastic polyposis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/29,33,34\">",
"     29,33,34",
"    </a>",
"    ]. In a retrospective cohort study of 1639 first and second degree relatives of patients with hyperplastic polyposis recruited from genetics clinics, the incidence of CRC and pancreatic cancer was increased in first degree relatives compared with the general population (CRC SIR first degree relative 5.2, 95% CI 3.7-7.3, pancreatic cancer SIR first degree relative 3.6, 95% CI 1.7-9.2) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, management strategies for patients with serrated polyposis syndrome and their families have not been well defined. Proximal polyps should be resected completely. Where there are many such flat polyps in the thin proximal colon, the risks of endoscopic resection (perforation, bleeding) should be carefully weighed against the risks and benefits of colectomy, giving consideration to the age and comorbidities of the patient, available colonoscopic expertise, the number and configuration of the polyps, and the definitive prophylaxis provided by surgery, including minimally invasive laparoscopic surgery in centers with such experience [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We recommend annual colonoscopy in patients who meet the clinical criteria for the serrated polyposis syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/16,21\">",
"     16,21",
"    </a>",
"    ]. These recommendations are consistent with the United States Multi-Society Task Force on Colorectal Cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/21\">",
"     21",
"    </a>",
"    ]. However, these recommendations are supported by limited evidence and other experts have recommended that colonoscopy be performed every two years in patients with serrated polyposis syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We suggest screening colonoscopies for first degree relatives of individuals with serrated polyposis around age 40 (or 10 years earlier than the earliest age at diagnosis in the family) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/16,29\">",
"     16,29",
"    </a>",
"    ]. We suggest a surveillance interval of five years if no polyps are found.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26828552\">",
"    <span class=\"h3\">",
"     Sessile serrated adenoma/polyps and traditional serrated adenomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sessile serrated",
"    <span class=\"nowrap\">",
"     adenomas/polyps",
"    </span>",
"    <span class=\"nowrap\">",
"     (SSA/Ps)",
"    </span>",
"    are more prevalent in the proximal colon and typically lack classic dysplasia. Foci of classic cytologic dysplasia do occur in",
"    <span class=\"nowrap\">",
"     SSA/Ps",
"    </span>",
"    and this should be noted by the pathologist as it is an important step toward cancer progression. In contrast, traditional serrated adenomas (TSAs) are more prevalent in the rectosigmoid and have diffuse but often mild cytologic dysplasia. Classification systems for these polyps are still evolving. Histological interpretation of these serrated polyp types differs among pathologists [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/37-39\">",
"     37-39",
"    </a>",
"    ]. The majority of studies suggest that TSAs and SSPs have significant malignant potential and are associated with subsequent development of metachronous polyps [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/27,28,37,40-47\">",
"     27,28,37,40-47",
"    </a>",
"    ]. Some studies suggest that",
"    <span class=\"nowrap\">",
"     SSA/Ps",
"    </span>",
"    have a higher potential to develop CRC compared with adenomatous polyps (tubular, tubulovillous, or villous) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/48\">",
"     48",
"    </a>",
"    ] and others have indicated a similar or lower potential [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/49-51\">",
"     49-51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <span class=\"nowrap\">",
"     SSA/Ps,",
"    </span>",
"    particularly those with foci of classic histologic dysplasia, are considered the likely precursor lesions to sporadic MSI-H colon cancer through studies of their molecular profiles that include inactivation through methylation of genes such as DNA repair genes MLH-1",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    0-6-methylguanine DNA methyltransferase (MGMT) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/17,52,53\">",
"     17,52,53",
"    </a>",
"    ]. Activation of the",
"    <em>",
"     BRAF",
"    </em>",
"    oncogene is also a feature of",
"    <span class=\"nowrap\">",
"     SSA/Ps,",
"    </span>",
"    as well as many hyperplastic polyps and the better studied sporadic MSI-H cancers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. Patterns of cellular proliferation and differentiation including mucus expression can also help differentiate",
"    <span class=\"nowrap\">",
"     SSA/Ps",
"    </span>",
"    from hyperplastic polyps [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/33/30234?source=see_link\">",
"     \"Molecular genetics of colorectal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Large serrated polyps have been associated with the presence of synchronous colorectal cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/28,43\">",
"     28,43",
"    </a>",
"    ]. They may also contain areas of classic dysplasia and focal cancer. In one report, 37 percent of these serrated adenomas contained areas of \"significant\" dysplasia and 11 percent had foci of intramucosal carcinoma (high-grade dysplasia), highlighting their malignant potential and the need for pathologic scrutiny [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    TSAs and",
"    <span class=\"nowrap\">",
"     SSA/Ps",
"    </span>",
"    are managed clinically like adenomatous polyps (see",
"    <a class=\"local\" href=\"#H27\">",
"     'Surveillance'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Adenomatous polyps",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adenomatous polyps are neoplastic polyps. About two-thirds of all colonic polyps are adenomas. Adenomas are by definition dysplastic and thus have malignant potential. Nearly all colorectal cancers arise from adenomas, but only a small minority of adenomas progress to cancer (5 percent or less). Studies reporting the average age at presentation of patients with adenomatous polyps versus colorectal cancer suggest the time for development of adenomas to cancer is about 7 to 10 years. The risk of progression is faster for advanced adenomas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Definitions",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An advanced adenoma is an adenoma with high-grade dysplasia, an adenoma that is &gt;10 mm in size, or an adenoma with a villous component. Adenomas without villous components are also referred to as tubular adenomas.",
"     </li>",
"     <li>",
"      A synchronous adenoma is an adenoma that is diagnosed at the same time as an index colorectal neoplasm (a pathologically more advanced lesion). Thirty to fifty percent of colons with one adenoma will contain at least one other synchronous adenoma [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/58\">",
"       58",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A metachronous adenoma is an adenoma that is diagnosed at least six months after the diagnosis of a previous adenoma.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Epidemiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of adenomatous polyps is variable and a number of risk factors have been identified. Older age is a major risk factor for the development of colonic adenomas. Colonoscopic screening studies in asymptomatic people suggest that the prevalence of adenomas is about 25 to 30 percent at age 50 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/57,59-62\">",
"     57,59-62",
"    </a>",
"    ]. Autopsy studies have found rates as high as 50 percent by age 70 (",
"    <a class=\"graphic graphic_figure graphicRef55319 \" href=\"mobipreview.htm?7/18/7469\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/63\">",
"     63",
"    </a>",
"    ], compared with only 1 to 4 percent in those in their twenties or thirties [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/62\">",
"     62",
"    </a>",
"    ]. Advancing age is also a risk factor for right-sided polyps [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/64\">",
"     64",
"    </a>",
"    ]. An increased body mass index (BMI) is associated with an increased risk of colorectal adenomas. In a meta-analysis of 36 studies, the risk for colorectal adenomas increased by 19 percent for every 5-unit increase in BMI (summary relative risk 1.19; 95% CI 1.13-1.26) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/65\">",
"     65",
"    </a>",
"    ]. Abdominal obesity, measured by increasing abdominal visceral adipose tissue volume, may be a better predictor than BMI or waist circumference in both sexes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/66\">",
"     66",
"    </a>",
"    ]. Lack of physical activity is also a risk factor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adenomatous polyps are more common in men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/61,68\">",
"     61,68",
"    </a>",
"    ], and large adenomas (&ge;9 mm) may be more common in African-Americans than Caucasians [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/69\">",
"     69",
"    </a>",
"    ]. In addition, African-Americans may have a higher risk of right-sided colonic adenomas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/70\">",
"     70",
"    </a>",
"    ] and present with cancer at a younger age (&lt;50 years of age) than Caucasians [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/71\">",
"     71",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/10/37034?source=see_link\">",
"     \"Screening for colorectal cancer: Strategies in patients at average risk\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The prevalence of advanced colonic adenomas, which are associated with a higher risk of colon cancer, is much lower. In a meta-analysis of average risk individuals, the prevalence was 3.8 percent in patients under age 65 and 8.2 percent in older patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Morphologic/endoscopic classification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polyps are further categorized as sessile, pedunculated, flat, or depressed.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sessile &ndash; Sessile polyps are those in which the base is attached to the colon wall.",
"     </li>",
"     <li>",
"      Pedunculated &ndash; Pedunculated polyps are polyps in which a mucosal stalk is interposed between the polyp and the wall (",
"      <a class=\"graphic graphic_picture graphicRef66254 \" href=\"mobipreview.htm?29/58/30628\">",
"       picture 5",
"      </a>",
"      ). Small polyps (&lt;5 mm, also known as \"diminutive polyps\") are rarely pedunculated.",
"     </li>",
"     <li>",
"      Flat &ndash; Flat polyps are those having a height less than one-half the diameter of the lesion. It is important to appreciate that while adenomas are most commonly found within raised lesions, up to 27 to 36 percent are relatively \"flat\" [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/49,72-74\">",
"       49,72-74",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Some studies have found that \"flat\" adenomas (by the definition given above) tend to be relatively advanced histologically for their size compared with polypoid lesions [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/72,73,75\">",
"       72,73,75",
"      </a>",
"      ]. However, their natural history is poorly understood [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/74\">",
"       74",
"      </a>",
"      ]. The National Polyp Study suggested that patients with one or more flat adenomas at an initial colonoscopy were not at greater risk for advanced adenomas at surveillance compared with those with polypoid adenomas only [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/73\">",
"       73",
"      </a>",
"      ]. On the other hand, flat lesions can be difficult to detect on colonoscopy, raising concern that such lesions may contribute to false negative colonoscopic evaluations.",
"     </li>",
"     <li>",
"      Depressed &ndash; Depressed lesions appear to be particularly likely to harbor high-grade dysplasia or be malignant, even if small [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/3,75-79\">",
"       3,75-79",
"      </a>",
"      ]. Up to 1 percent of adenomas are depressed [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/49,72-74\">",
"       49,72-74",
"      </a>",
"      ]. Although flat and depressed adenomas were initially thought to be largely a phenomenon in Asia only, they have now been shown to occur more frequently than previously recognized in western populations [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/75,80-83\">",
"       75,80-83",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Pathologic classification",
"    </span>",
"    &nbsp;&mdash;&nbsp;All adenomas are dysplastic. Two grades of dysplasia (high and low) are recognized. The terms \"carcinoma in situ\" or \"intramucosal adenocarcinoma\" should both be described as high-grade dysplasia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/23,84\">",
"     23,84",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Polyps with high-grade dysplasia do not contain invasive malignancy, which is defined by a breach of the muscularis mucosa by neoplastic cells. Because there are no lymphatic vessels in the lamina propria, they are not associated with metastasis. High-grade dysplasia represents an intermediate step in the evolution from a low-grade adenomatous polyp to cancer, and in some studies, is a significant risk factor for subsequent (metachronous) colorectal malignancy in the individual after its removal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/85\">",
"     85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The proliferative zone in adenomas, as measured with Ki67 expression through immunohistochemistry, predominates in the upper part of the crypt, although sometimes there is a diffuse pattern [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/17\">",
"     17",
"    </a>",
"    ]. This is also assessable on H and E stained sections, assisting the pathologist in diagnosis.",
"   </p>",
"   <p>",
"    The glandular architecture of adenomas is characterized as tubular, villous, or a mixture of the two [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/23\">",
"     23",
"    </a>",
"    ]. In addition, a class of polyps known as serrated adenomas has a distinctive pathology (see",
"    <a class=\"local\" href=\"#H26828552\">",
"     'Sessile serrated adenoma/polyps and traditional serrated adenomas'",
"    </a>",
"    above).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h4\">",
"     Tubular",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tubular adenomas account for more than 80 percent of colonic adenomas. They are characterized by a network of branching adenomatous epithelium (",
"    <a class=\"graphic graphic_picture graphicRef51968 graphicRef63727 \" href=\"mobipreview.htm?28/2/28714\">",
"     picture 7A-B",
"    </a>",
"    ). To be classified as tubular, the adenoma should have a tubular component of at least 75 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h4\">",
"     Villous",
"    </span>",
"    &nbsp;&mdash;&nbsp;Villous adenomas account for 5 to 15 percent of adenomas (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61015 \" href=\"mobipreview.htm?33/27/34238\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef60933 \" href=\"mobipreview.htm?39/4/40000\">",
"     picture 8",
"    </a>",
"    ). They are characterized by glands that are long and extend straight down from the surface to the center of the polyp (",
"    <a class=\"graphic graphic_picture graphicRef70756 \" href=\"mobipreview.htm?32/24/33157\">",
"     picture 9",
"    </a>",
"    ). To be classified as villous, the adenoma should have a villous component of at least 75 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h4\">",
"     Tubulovillous adenomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tubulovillous adenomas having 26 to 75 percent villous component account for 5 to 15 percent of adenomas.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Clinical presentation and natural history",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adenomas are generally asymptomatic and are most often detected by colon cancer screening tests. Small adenomas do not typically bleed, rendering fecal occult blood testing (FOBT) an insensitive screening method. Advanced adenomas (see below) are more likely to bleed and cause a positive fecal occult blood test, especially with immunochemical testing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/86\">",
"     86",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The growth rates of adenomatous polyps are variable and do not follow a consistent linear trend. The majority of small polyps exhibit minimal growth (averaging 0.5",
"    <span class=\"nowrap\">",
"     mm/year).",
"    </span>",
"    Prospective observations suggest that complete regression is uncommon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/87\">",
"     87",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When considering polyp characteristics, the risk that a particular polyp morphology will be associated with malignancy in that polyp at that time should be distinguished from the same characteristics being used as a risk factor for metachronous adenomas or cancers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Risk factors for high-grade dysplasia and cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;Villous histology, increasing polyp size, and high-grade dysplasia are risk factors for focal cancer within an individual adenoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/23\">",
"     23",
"    </a>",
"    ]. Number and size are the most consistent risk factors for metachronous adenomas including advanced adenomas and cancer.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Polyp size &ndash; Adenomatous polyps &gt;1 cm in diameter are a risk factor for containing colorectal cancer and are also a risk factor for metachronous cancer development [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/88\">",
"       88",
"      </a>",
"      ]. The majority of adenomas (60 to 75 percent) are less than 1 cm at endoscopy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/23,89\">",
"       23,89",
"      </a>",
"      ]. These results are supported by reports which have found no increased risk of cancer among patients with small polyps treated by fulguration without subsequent surveillance [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/90\">",
"       90",
"      </a>",
"      ], but up to a fourfold increase in cancer risk during follow-up of patients with polyps &gt;1 cm in size [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/91\">",
"       91",
"      </a>",
"      ]. One report found that patients with only one or two tubular adenomas less than 1 cm had a low risk of colonic neoplasia after five years of follow-up [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/92\">",
"       92",
"      </a>",
"      ]. A study of pooled data from eight prospective studies reported that the absolute risk of metachronous advanced adenomas approached 20 percent in patients whose largest baseline adenoma was 20 mm in size or greater [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/93\">",
"       93",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Size versus villous histology &ndash; The proportion of adenomas showing advanced histologic features (high-grade dysplasia or &gt;25 percent villous histology) increases from approximately 1 to 2 percent in small adenomas (&lt;5 mm) to 7 to 12 percent for medium-sized adenomas (5 to 10 mm) and 20 to 30 percent for large adenomas (&gt;1 cm) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/88,94,95\">",
"       88,94,95",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Adenomatous polyps with &gt;25 percent villous histology are a risk factor for developing metachronous colorectal cancer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/88\">",
"       88",
"      </a>",
"      ]. In some studies, villosity also predicts metachronous advanced adenomas, although villosity is often closely linked with size and is not independently predictive in all studies.",
"     </li>",
"     <li>",
"      High-grade dysplasia &ndash; Adenomas with high-grade dysplasia often coexist with areas of invasive cancer in the polyp. Older age is also associated with high-grade dysplasia within an adenoma, independent of size and histology [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/23\">",
"       23",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Adenomatous polyps with high-grade dysplasia and adenomatous polyps with invasive cancer (",
"      <a class=\"graphic graphic_picture graphicRef70756 \" href=\"mobipreview.htm?32/24/33157\">",
"       picture 9",
"      </a>",
"      ) are risk factors for developing metachronous colorectal cancer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/88\">",
"       88",
"      </a>",
"      ]. However, as size and levels of dysplasia are closely linked, most multivariate analyses are unable to separate high-grade dysplasia from size in predicting metachronous risk.",
"     </li>",
"     <li>",
"      Number of polyps &ndash; Numbers of adenomas at colonoscopy and cumulatively over a lifetime is the most consistent risk factor for metachronous colorectal cancer. The presence of one or more advanced adenomas predicts a higher rate of both any and advanced metachronous adenomas [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/85\">",
"       85",
"      </a>",
"      ]. The risk of metachronous colon cancer (eg, diagnosed six months after removal of an index cancer or polyp) increases with the number of advanced adenomas that are present [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/88\">",
"       88",
"      </a>",
"      ]. In one report, for example, patients with multiple large or villous rectosigmoid adenomas had a 6.6-fold higher risk of subsequent malignancy than the control population [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/85\">",
"       85",
"      </a>",
"      ]. Another report found that large polyp size (&gt;1 cm) and proximally located adenomas were independent predictors of recurrent high-risk adenomas [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/96\">",
"       96",
"      </a>",
"      ]. A study of pooled data from eight prospective studies, proposed that absolute risks of metachronous advanced adenomas, colorectal cancer, and their combination (advanced colorectal neoplasia) within three to five years is higher (24 percent) in patients with &gt;4 adenomas at baseline [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/93\">",
"       93",
"      </a>",
"      ]. The risk for metachronous advanced adenomas increased with the number of adenomas at baseline and was 9, 13, 15, 20, and 24 percent for 1, 2, 3, 4, or &ge;5 adenomas at baseline, respectively.",
"     </li>",
"     <li>",
"      The number of adenomas, particularly three or more, was the sole risk factor for development of metachronous adenomas with advanced pathologic features.",
"      <br/>",
"      <br/>",
"      Studies suggest that patients with a limited number of small, tubular, adenomatous polyps removed do not have a significantly increased metachronous colon cancer risk.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;The eradication of colonic adenomas is important for minimizing cancer risk and mortality. This is supported by the observation of a decrease in the incidence of colorectal cancer in the United States with the introduction of widespread screening [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/97\">",
"     97",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/25/42394?source=see_link\">",
"     \"Colorectal cancer: Epidemiology, risk factors, and protective factors\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although the benefit of removing small polyps was not specifically addressed, the National Polyp Study reported that endoscopic removal of all adenomas resulted in a 76 to 90 percent decrease in cancer incidence when compared with three separate historic reference groups (",
"    <a class=\"graphic graphic_figure graphicRef81546 \" href=\"mobipreview.htm?21/61/22494\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/98\">",
"     98",
"    </a>",
"    ]. In addition, the National Polyp Study found that during long-term follow-up (up to 23 years), patients who had adenomas removed had an estimated 53 percent reduction in mortality due to colon cancer compared with the expected number of deaths in the general population (standardized incidence-based mortality ratio 0.47, 95% CI 0.26-0.80) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/99\">",
"     99",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, some studies of patients with adenomas in follow-up have not demonstrated reductions in cancer risk when compared with average-risk populations, although their initial higher-risk status was likely reduced to average-risk following polypectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/100\">",
"     100",
"    </a>",
"    ]. In a report from three adenoma trials, colorectal cancer was diagnosed in 19 of the 2915 patients who had removal of at least one adenoma and were deemed free of remaining lesions over a mean follow-up of 3.7 years (incidence of 1.74",
"    <span class=\"nowrap\">",
"     cancers/1000",
"    </span>",
"    person-years) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/101\">",
"     101",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A randomized controlled trial of screening for colon cancer through fecal occult blood testing not only demonstrated a reduced mortality from colon cancer (principally through detection of early stage and curable cancers) but also, at a later time, a reduction in the incidence of colon cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/102\">",
"     102",
"    </a>",
"    ]. In addition, in a population-based, case-controlled study, colonoscopy was associated with fewer deaths from colorectal cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/103\">",
"     103",
"    </a>",
"    ]. This association was primarily limited to deaths from cancer developing in the left side of the colon.",
"   </p>",
"   <p>",
"    In a multicenter randomized controlled trial, once-only flexible sigmoidoscopy screening showed not only a reduction in mortality from distal bowel cancer (hazard ratio 0.50, 95% CI 0.42-0.59) and total colorectal cancer mortality (hazard ratio 0.69, 95% CI 0.59-0.82) after median follow-up of 11.2 years, but also a reduction in colorectal cancer incidence (through adenoma removal) (hazard ratio 0.77, 95% CI 0.70-0.84), strongly supporting the adenoma-cancer sequence as a major pathway to colorectal cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/104\">",
"     104",
"    </a>",
"    ]. These findings have been confirmed in the United States Prostate, Lung, Cancer, and Ovarian (PLCO) trial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/105\">",
"     105",
"    </a>",
"    ]. These findings are attributed to the detection and removal of adenomatous polyps through a screening program.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h4\">",
"     Detection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Colonoscopy is considered to be the optimal examination for the detection of adenomatous polyps, particularly in view of the ability to provide therapeutic polypectomy in conjunction with diagnosis. The superior sensitivity of colonoscopy over that of double-contrast",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    enema and computed tomographic colonography is particularly evident when diminutive or flat polyps are considered, since they are unable to visualize the majority of these small adenomas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/106,107\">",
"     106,107",
"    </a>",
"    ]. In addition, an optimally performed double-contrast barium enema will detect only approximately one-half of adenomas 5 mm or more in size that are evident on colonoscopy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/9/38042?source=see_link\">",
"     \"Tests for screening for colorectal cancer: Stool tests, radiologic imaging and endoscopy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/49/36632?source=see_link\">",
"     \"Computed tomographic colonography\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, colonoscopy is not perfect. One report found that the colonoscopic miss rate determined by two same-day endoscopic examinations in 183 patients was 27 percent for adenomas &lt;5 mm, 13 percent for those 6 to 9 mm, and 6 percent for adenomas &gt;1 cm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/108\">",
"     108",
"    </a>",
"    ]. Multiple factors likely contribute to missed polyps at colonoscopy including the quality of the prep, the training and experience of the endoscopist, and perhaps even the degree of fatigue of the endoscopist. The amount of time taken by colonoscopists during withdrawal of the colonoscope has emerged as a powerful predictor of adenoma detection rate in some studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/109\">",
"     109",
"    </a>",
"    ]. Interval or missed cancer rates have been linked inversely to adenoma detection rates at screening colonoscopy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/110\">",
"     110",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In general, evidence suggests that protection afforded by colonoscopy for right-sided cancer development is significantly less than left-sided cancer in a range of settings, raising questions of the quality of colonoscopy as it relates particularly to the right colon (poor right-sided preps, incomplete colonoscopy, anatomical configurations compromising visibility, or differential biology for right-sided lesions) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/103,111\">",
"     103,111",
"    </a>",
"    ]. This behoves endoscopists to pay particular attention to the right colon in their practices both at initial and at follow-up examinations.",
"   </p>",
"   <p>",
"    Other technologies (chromoendoscopy, magnification endoscopy, narrow band imaging optical colonoscopy, confocal endomicroscopy) have been used to increase colorectal cancer colonoscopy detection, but their value in screening for colorectal cancer has yet to be determined. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/9/38042?source=see_link\">",
"     \"Tests for screening for colorectal cancer: Stool tests, radiologic imaging and endoscopy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/0/15370?source=see_link\">",
"     \"Chromoendoscopy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/9/4248?source=see_link\">",
"     \"Magnification endoscopy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/2/3113?source=see_link\">",
"     \"Confocal laser endomicroscopy and endocytoscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h4\">",
"     Polypectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of techniques are used during colonoscopy to remove polyps:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Cold biopsy forceps",
"     </li>",
"     <li>",
"      Hot (monopolar) biopsy forceps",
"     </li>",
"     <li>",
"      Cold snare excision",
"     </li>",
"     <li>",
"      Standard snare excision (with monopolar cautery)",
"     </li>",
"     <li>",
"      Simple fulguration, including with argon plasma coagulation",
"     </li>",
"     <li>",
"      Piecemeal excision",
"     </li>",
"     <li>",
"      Saline assisted endoscopic mucosal resection",
"     </li>",
"     <li>",
"      Endoscopic submucosal dissection",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Snare excision is commonly used for polyps &gt;5 to 10 mm and offers the most complete removal of adenomatous tissue. Diminutive lesions can be readily removed with either biopsy forceps or by snare polypectomy. Some advocate the use of cold forceps biopsy or cold snare excision for small polyps in the cecum and ascending colon because of the higher complication rate noted with hot biopsy in these areas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/18\">",
"     18",
"    </a>",
"    ]. Residual polyp tissue remains a theoretical concern with excision by hot biopsy (17 percent incomplete removal) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/112\">",
"     112",
"    </a>",
"    ] or cold biopsy (29 percent incomplete removal) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/113\">",
"     113",
"    </a>",
"    ], but the significance of this is unclear and probably minimal.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Large polyps &ndash; The optimal method of colonoscopic removal of large polyps (&gt;10 mm) varies with the type of polyp. Large pedunculated polyps readily lend themselves to snare removal.",
"     </li>",
"     <li>",
"      Sessile polyps &ndash; In comparison, large sessile adenomas (&gt;2 to 3 cm) often require piecemeal resection. The presence of a large sessile adenoma is predictive of synchronous advanced neoplasia, making it particularly important that the colon is carefully inspected [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Complete and safe removal of larger sessile lesions may be aided by the saline lift technique, which prepares the polyp for resection by first raising it from the underlying muscularis propria by injecting saline (sometimes tinged with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/7/1143?source=see_link\">",
"     methylene blue",
"    </a>",
"    to highlight the planes) into the submucosa under the polyp. Vigilant follow-up, with initial colonoscopy intervals of three to six months, is warranted for these larger sessile lesions since 28 percent recur or persist, and 17 percent later degenerate into carcinoma despite apparently complete removal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/114\">",
"     114",
"    </a>",
"    ]. Endoscopic submucosal dissection allows en bloc dissection of polyps but requires specialized techniques, accessories, and expertise. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/18/28968?source=see_link\">",
"     \"Endoscopic removal of large colonic polyps\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When large polyps are present in the rectum, consideration should be given to referring the patient for a transanal endoscopic microsurgery (TEMS) procedure, as there is a greater likelihood of removing the specimen in one piece, considerably enhancing subsequent decision making if cancer is found in the specimen. If resection is piecemeal, adequacy of removal may be impossible to determine pathologically, and the patient potentially could be committed to an unnecessary abdominoperineal resection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/18/28968?source=see_link\">",
"     \"Endoscopic removal of large colonic polyps\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h4\">",
"     Approach to management",
"    </span>",
"    &nbsp;&mdash;&nbsp;If a polyp is detected by",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    enema or computed tomographic colonography, colonoscopy is recommended to establish the histology, remove the polyp, and search for synchronous lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/115,116\">",
"     115,116",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Small polyps found at colonoscopy should be completely removed by biopsy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      by electrocautery techniques. If numerous (&gt;20) small polyps are encountered, representative biopsies of a substantial sample of the polyp number should be obtained, as syndromic diagnosis (and therefore the gene to be analyzed) is dependent on this. Sampling should be generous, if not complete.",
"     </li>",
"     <li>",
"      The number of adenomas, regardless of size, is a dominant factor in metachronous adenoma and cancer risk. Whether the important parameter of number of adenomas should be calculated as cumulative lifetime adenomas or adenomas at the current colonoscopy for the purposes of follow-up recommendations is not clear. Pragmatically, the number at the current colonoscopy is usually assimilated into the risk assessment, as the cumulative number is often difficult to ascertain in clinical practice.",
"     </li>",
"     <li>",
"      After colonoscopic removal of a large (&gt;2 cm) sessile polyp, follow-up colonoscopy should usually be performed in three to four months (when edema has resolved) if there is concern that any portion of the adenoma has not been completely removed. If residual polyp tissue remains, it should be excised and the colonoscopy repeated in another three to six months. Surgical removal should be considered if complete resection cannot be accomplished after two to three colonoscopic attempts.",
"     </li>",
"     <li>",
"      High-grade dysplasia is considered noninvasive if these lesions are found within a resected polyp; they require no further therapy if the resection margins are free of neoplastic tissue [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/117\">",
"       117",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some adenomas with early invasive cancer also have a low (&lt;2 percent) risk of lymphatic metastasis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/118\">",
"     118",
"    </a>",
"    ], and polypectomy alone is usually adequate for such lesions. No further treatment is necessary if specific pathologic criteria are met [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/115\">",
"     115",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The polyp is considered to be completely excised by the endoscopist and is submitted in toto for pathological examination.",
"     </li>",
"     <li>",
"      The polyp is fixed and sectioned so that it is possible to accurately determine the depth of invasion, grade of differentiation, and completeness of excision of the carcinoma.",
"     </li>",
"     <li>",
"      The cancer is not poorly differentiated.",
"     </li>",
"     <li>",
"      There is no vascular or lymphatic involvement.",
"     </li>",
"     <li>",
"      The margin of the excision is not involved. Invasion of the stalk of pedunculated polyp, by itself, is not an unfavorable prognostic finding, as long as the cancer does not extend to the margin of stalk resection.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    When all of these low-risk criteria are not met, the decision to proceed to surgical resection needs to be individualized, taking into account the age and comorbidity of the patient. Surgical resection is generally recommended for any invasive cancer in a sessile adenoma where the patient is otherwise well. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/49/30489?source=see_link\">",
"     \"Overview of the management of primary colon cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Surveillance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple studies have examined the risk of advanced colorectal neoplasia in patients with previously endoscopically resected colorectal adenomas to quantify their risk of developing a subsequent advanced adenoma or cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/93,119\">",
"     93,119",
"    </a>",
"    ]. A pooled analysis of eight prospective studies (with a total of 9167 subjects) estimated that the risk of advanced colorectal neoplasia was 12 percent during a median follow-up of four years; 58 patients (0.6 percent) developed invasive cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/93\">",
"     93",
"    </a>",
"    ]. The strongest risk factors were advanced neoplasia in the initial polypectomy, older age, and the number and size of prior adenomas.",
"   </p>",
"   <p>",
"    The studies summarized above provided the basis for the 2012 guidelines for colonoscopy surveillance after screening polypectomy endorsed by the American Gastroenterological Association (AGA), the American Society for Gastrointestinal Endoscopy, the American College of Gastroenterology, the American College of Radiology, and the American Cancer Society (",
"    <a class=\"graphic graphic_table graphicRef86494 \" href=\"mobipreview.htm?2/50/2861\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Low-risk adenomas &ndash; If only one or two small (&le;5 mm) tubular adenomas are found on baseline colonoscopy, the first surveillance colonoscopy should be performed in 5 to 10 years. If no adenomas are found on the first surveillance colonoscopy, a second surveillance colonoscopy should be performed in 10 years. However, if a low-risk adenoma is detected, the second surveillance colonoscopy should be performed at five years (",
"      <a class=\"graphic graphic_table graphicRef86495 \" href=\"mobipreview.htm?23/1/23579\">",
"       table 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Advanced adenomas &ndash; Individuals with advanced adenomas (&ge;10 mm, villous histology or high-grade dysplasia) at baseline colonoscopy should undergo a first surveillance colonoscopy in three years. Individuals with a low-risk adenoma or no adenomas on their first surveillance colonoscopy should undergo a second surveillance colonoscopy in five years, whereas those with an advanced adenoma or three more adenomas should undergo their second surveillance colonoscopy in three years (",
"      <a class=\"graphic graphic_table graphicRef86495 \" href=\"mobipreview.htm?23/1/23579\">",
"       table 3",
"      </a>",
"      ).",
"      <br/>",
"      <br/>",
"      Results from the National Polyp Study suggested that a three-year interval for surveillance colonoscopy is safe and cost-effective for the majority of patients with advanced adenomatous polyp [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/98\">",
"       98",
"      </a>",
"      ]. Longer intervals can be instituted in patients with low-risk adenomas [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/85\">",
"       85",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      However, the ability to discriminate the risk of recurrence based solely upon histologic features is limited. In one report, for example, the probability of advanced adenoma recurrence within four years was 9 percent in those with a high-risk adenoma at baseline compared with 5 percent in those with low-risk adenomas at baseline [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/120\">",
"       120",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Among patients who had an advanced adenoma removed on a previous colonoscopy, a negative first repeat colonoscopy does not necessarily imply a good prognosis. This was illustrated in a study of 564 patients who had a colonic adenoma removed on colonoscopy followed by two subsequent colonoscopies at approximately three-year intervals [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/121\">",
"       121",
"      </a>",
"      ]. Among patients in whom the first follow-up colonoscopy was negative, the findings on the initial positive colonoscopy had prognostic value for the second follow-up colonoscopy. The probability of high-risk findings was significantly increased in patients with a high-risk compared to low-risk initial adenoma (12 versus 5 percent).",
"     </li>",
"     <li>",
"      Serrated",
"      <span class=\"nowrap\">",
"       adenomas/polyp",
"      </span>",
"      <span class=\"nowrap\">",
"       (SSA/P)",
"      </span>",
"      &ndash; Patients with",
"      <span class=\"nowrap\">",
"       SSA/P",
"      </span>",
"      that are &lt;10 mm and no dysplasia should undergo a repeat colonoscopy in five years. Studies have demonstrated that proximal and large",
"      <span class=\"nowrap\">",
"       SSA/P",
"      </span>",
"      (&ge;10 mm) are markers of a synchronous advanced adenoma [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/27,28\">",
"       27,28",
"      </a>",
"      ]. Thus, individuals with",
"      <span class=\"nowrap\">",
"       SSA/P",
"      </span>",
"      &ge;10 mm and a",
"      <span class=\"nowrap\">",
"       SSA/P",
"      </span>",
"      with dysplasia should undergo a repeat colonoscopy at three years. These recommendations for surveillance are consistent with United States multi-society guidelines [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/21\">",
"       21",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Other expert consensus recommendations have suggested earlier colonoscopic follow-up (one- to three-year interval) in individuals with two or more",
"      <span class=\"nowrap\">",
"       SSA/P",
"      </span>",
"      larger than 10 mm and in those with any",
"      <span class=\"nowrap\">",
"       SSA/P",
"      </span>",
"      with cytologic dysplasia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/16\">",
"       16",
"      </a>",
"      ]. However, prospective data to support the",
"      <span class=\"nowrap\">",
"       screening/surveillance",
"      </span>",
"      intervals are lacking. (See",
"      <a class=\"local\" href=\"#H26828552\">",
"       'Sessile serrated adenoma/polyps and traditional serrated adenomas'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H26828020\">",
"       'Serrated polyposis syndrome'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Attempts to prevent colorectal adenomatous polyps through diet and chemoprevention have been evaluated.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diet &ndash; A diet that is low in fat and high in fruits, vegetables, and fiber has been recommended, although based upon limited data [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/115\">",
"       115",
"      </a>",
"      ]. There may be advantages with cruciferous vegetables and unprocessed forms of cereal fiber. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/24/42378?source=see_link&amp;anchor=H11#H11\">",
"       \"Cancer prevention\", section on 'Fiber'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Also suggested are maintenance of normal body weight through regular exercise and caloric restriction, dietary calcium supplementation, and avoidance of smoking and excessive alcohol use, especially beer.",
"      <br/>",
"      <br/>",
"      Studies of calcium have focused on metachronous adenoma occurrence; a benefit of calcium on colorectal cancer prevention has not been demonstrated. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/25/42394?source=see_link\">",
"       \"Colorectal cancer: Epidemiology, risk factors, and protective factors\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      COX-2 agents &ndash; Large trials of the COX-2 agents,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/11/40120?source=see_link\">",
"       celecoxib",
"      </a>",
"      and rofecoxib, demonstrated significant reductions in advanced and metachronous adenomas, particularly at high dosages of the agents (eg, celecoxib 800 mg daily) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/122-124\">",
"       122-124",
"      </a>",
"      ]. However, vascular events of strokes and myocardial infarctions were significantly higher in the groups randomized to the high doses (including rofecoxib 25 mg), effectively preventing their use in chemoprevention [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/125\">",
"       125",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       Aspirin",
"      </a>",
"      &ndash; Aspirin also reduces the incidence of metachronous adenomas and probably cancer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/126\">",
"       126",
"      </a>",
"      ]. The role of aspirin in cancer prevention is discussed in detail separately. &nbsp;(See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/8/22666?source=see_link\">",
"       \"NSAIDs (including aspirin): Role in prevention of cancer\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/5/29783?source=see_link\">",
"       \"Lynch syndrome (hereditary nonpolyposis colorectal cancer): Screening and management of patients and families\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/5/12373?source=see_link\">",
"       Ursodeoxycholic acid",
"      </a>",
"      &ndash; A controlled trial of ursodeoxycholic acid (a synthetic bile salt) did not find a statistically significant reduction in metachronous colorectal adenomas overall, although there was a significant reduction in the risk of adenomas with high-grade dysplasia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/62/32746/abstract/127\">",
"       127",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/5/9298?source=see_link\">",
"       \"Patient information: Colon polyps (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?18/11/18611?source=see_link\">",
"       \"Patient information: Colonoscopy (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?20/47/21234?source=see_link\">",
"       \"Patient information: Familial adenomatous polyposis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?25/9/25747?source=see_link\">",
"       \"Patient information: Colon polyps (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?9/30/9698?source=see_link\">",
"       \"Patient information: Colonoscopy (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?41/12/42176?source=see_link\">",
"       \"Patient information: Flexible sigmoidoscopy (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A polyp of the colon refers to a protuberance into the lumen from the normally flat colonic mucosa. Polyps are usually asymptomatic but may ulcerate and bleed, cause tenesmus if in the rectum, and, when very large, produce intestinal obstruction. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Colonic polyps are usually classified as non-neoplastic, hamartomatous, neoplastic (adenomas and carcinomas), serrated (which can be neoplastic or non-neoplastic), and submucosal (which can be neoplastic or non-neoplastic). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hyperplastic polyps are the most common non-neoplastic polyps in the colon. Distal small hyperplastic polyps rarely, if ever, develop into colorectal cancers. (See",
"      <a class=\"local\" href=\"#H26827993\">",
"       'Hyperplastic polyps'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Serrated polyposis syndrome (formerly known as hyperplastic polyposis syndrome [HPS]) refers to a condition characterized by multiple, large",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      proximal hyperplastic polyps and, occasionally, smaller numbers of serrated adenomas, adenomas, or mixed",
"      <span class=\"nowrap\">",
"       hyperplastic/adenomatous",
"      </span>",
"      polyps. Patients with serrated polyposis syndrome appear to be at increased risk of colorectal cancer. (See",
"      <a class=\"local\" href=\"#H26828020\">",
"       'Serrated polyposis syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Serrated polyps are a heterogenous group of polyps with variable malignant potential. They include hyperplastic polyps, traditional serrated adenomas, and sessile serrated polyps (also known as sessile serrated adenomas). (See",
"      <a class=\"local\" href=\"#H26827803\">",
"       'Serrated polyps'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hamartomatous polyps are polyps that are made up of tissue elements normally found at that site, but which are growing in a disorganized mass. Juvenile polyps, Peutz-Jeghers polyps, and Cronkhite-Canada syndrome, are hamartomatous polyps. Patients with juvenile polyposis coli and Peutz-Jeghers syndrome are at increased risk for cancer. (See",
"      <a class=\"local\" href=\"#H15416963\">",
"       'Hamartomatous polyps'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Adenomatous polyps are neoplastic polyps. About two-thirds of all colonic polyps are adenomas. Adenomas are by definition dysplastic and thus have malignant potential. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Adenomatous polyps'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Adenomatous polyps are categorized morphologically (sessile, pedunculated, flat, or depressed) and pathologically (high- or low-grade dysplasia as well as tubular, villous, and tubulovillous). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Morphologic/endoscopic classification'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16\">",
"       'Pathologic classification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clinically, adenomas are generally asymptomatic and are most often detected by colon cancer screening tests. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Clinical presentation and natural history'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Villous histology, increasing polyp size, and high-grade dysplasia are risk factors for focal cancer within an individual adenoma. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Risk factors for high-grade dysplasia and cancer'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If a polyp is detected, we recommend colonoscopy to establish the histology, remove the polyp, and search for synchronous lesions (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Recommendations for subsequent treatment and surveillance depend on the pathologic features of the polyp (",
"      <a class=\"graphic graphic_table graphicRef86494 \" href=\"mobipreview.htm?2/50/2861\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Approach to management'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H27\">",
"       'Surveillance'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/1\">",
"      Howe JR, Roth S, Ringold JC, et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 1998; 280:1086.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/2\">",
"      Chow E, Thirlwell C, Macrae F, Lipton L. Colorectal cancer and inherited mutations in base-excision repair. Lancet Oncol 2004; 5:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/3\">",
"      Howe JR, Bair JL, Sayed MG, et al. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 2001; 28:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/4\">",
"      CRONKHITE LW Jr, CANADA WJ. Generalized gastrointestinal polyposis; an unusual syndrome of polyposis, pigmentation, alopecia and onychotrophia. N Engl J Med 1955; 252:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/5\">",
"      Anderson RD, Patel R, Hamilton JK, Boland CR. Cronkhite-Canada syndrome presenting as eosinophilic gastroenteritis. Proc (Bayl Univ Med Cent) 2006; 19:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/6\">",
"      Yasuda T, Ueda T, Matsumoto I, et al. Cronkhite-Canada syndrome presenting as recurrent severe acute pancreatitis. Gastrointest Endosc 2008; 67:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/7\">",
"      Daniel ES, Ludwig SL, Lewin KJ, et al. The Cronkhite-Canada Syndrome. An analysis of clinical and pathologic features and therapy in 55 patients. Medicine (Baltimore) 1982; 61:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/8\">",
"      Zbuk KM, Eng C. Hamartomatous polyposis syndromes. Nat Clin Pract Gastroenterol Hepatol 2007; 4:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/9\">",
"      Sweetser S, Ahlquist DA, Osborn NK, et al. Clinicopathologic features and treatment outcomes in Cronkhite-Canada syndrome: support for autoimmunity. Dig Dis Sci 2012; 57:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/10\">",
"      Goto A. Cronkhite-Canada syndrome: epidemiological study of 110 cases reported in Japan. Nihon Geka Hokan 1995; 64:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/11\">",
"      Ward EM, Wolfsen HC. Pharmacological management of Cronkhite-Canada syndrome. Expert Opin Pharmacother 2003; 4:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/12\">",
"      Sampson JE, Harmon ML, Cushman M, Krawitt EL. Corticosteroid-responsive Cronkhite-Canada syndrome complicated by thrombosis. Dig Dis Sci 2007; 52:1137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/13\">",
"      Hornick JL, Fletcher CD. Intestinal perineuriomas: clinicopathologic definition of a new anatomic subset in a series of 10 cases. Am J Surg Pathol 2005; 29:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/14\">",
"      Groisman GM, Polak-Charcon S. Fibroblastic polyp of the colon and colonic perineurioma: 2 names for a single entity? Am J Surg Pathol 2008; 32:1088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/15\">",
"      Zamecnik M, Chlumska A. Perineurioma versus fibroblastic polyp of the colon. Am J Surg Pathol 2006; 30:1337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/16\">",
"      Rex DK, Ahnen DJ, Baron JA, et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 2012; 107:1315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/17\">",
"      Higuchi T, Sugihara K, Jass JR. Demographic and pathological characteristics of serrated polyps of colorectum. Histopathology 2005; 47:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/18\">",
"      Weston AP, Campbell DR. Diminutive colonic polyps: histopathology, spatial distribution, concomitant significant lesions, and treatment complications. Am J Gastroenterol 1995; 90:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/19\">",
"      Provenzale D, Garrett JW, Condon SE, Sandler RS. Risk for colon adenomas in patients with rectosigmoid hyperplastic polyps. Ann Intern Med 1990; 113:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/20\">",
"      Laiyemo AO, Murphy G, Sansbury LB, et al. Hyperplastic polyps and the risk of adenoma recurrence in the polyp prevention trial. Clin Gastroenterol Hepatol 2009; 7:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/21\">",
"      Lieberman DA, Rex DK, Winawer SJ, et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012; 143:844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/22\">",
"      Rex DK, Smith JJ, Ulbright TM, Lehman GA. Distal colonic hyperplastic polyps do not predict proximal adenomas in asymptomatic average-risk subjects. Gastroenterology 1992; 102:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/23\">",
"      O'Brien MJ, Winawer SJ, Zauber AG, et al. The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 1990; 98:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/24\">",
"      Bensen SP, Cole BF, Mott LA, et al. Colorectal hyperplastic polyps and risk of recurrence of adenomas and hyperplastic polyps. Polyps Prevention Study. Lancet 1999; 354:1873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/25\">",
"      Dave S, Hui S, Kroenke K, Imperiale TF. Is the distal hyperplastic polyp a marker for proximal neoplasia? J Gen Intern Med 2003; 18:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/26\">",
"      Lin OS, Schembre DB, McCormick SE, et al. Risk of proximal colorectal neoplasia among asymptomatic patients with distal hyperplastic polyps. Am J Med 2005; 118:1113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/27\">",
"      Schreiner MA, Weiss DG, Lieberman DA. Proximal and large hyperplastic and nondysplastic serrated polyps detected by colonoscopy are associated with neoplasia. Gastroenterology 2010; 139:1497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/28\">",
"      Hiraoka S, Kato J, Fujiki S, et al. The presence of large serrated polyps increases risk for colorectal cancer. Gastroenterology 2010; 139:1503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/29\">",
"      Chow E, Lipton L, Lynch E, et al. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology 2006; 131:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/30\">",
"      Renaut AJ, Douglas PR, Newstead GL. Hyperplastic polyposis of the colon and rectum. Colorectal Dis 2002; 4:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/31\">",
"      Edelstein DL, Axilbund JE, Hylind LM, et al. Serrated polyposis: rapid and relentless development of colorectal neoplasia. Gut 2013; 62:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/32\">",
"      Minoo P, Baker K, Goswami R, et al. Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 2006; 55:1467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/33\">",
"      Carvajal-Carmona LG, Howarth KM, Lockett M, et al. Molecular classification and genetic pathways in hyperplastic polyposis syndrome. J Pathol 2007; 212:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/34\">",
"      Buchanan DD, Sweet K, Drini M, et al. Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study. Int J Colorectal Dis 2010; 25:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/35\">",
"      Win AK, Walters RJ, Buchanan DD, et al. Cancer risks for relatives of patients with serrated polyposis. Am J Gastroenterol 2012; 107:770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/36\">",
"      Terdiman JP, McQuaid KR. Surveillance guidelines should be updated to recognize the importance of serrated polyps. Gastroenterology 2010; 139:1444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/37\">",
"      Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP. Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol 2005; 124:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/38\">",
"      Glatz K, Pritt B, Glatz D, et al. A multinational, internet-based assessment of observer variability in the diagnosis of serrated colorectal polyps. Am J Clin Pathol 2007; 127:938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/39\">",
"      Khalid O, Radaideh S, Cummings OW, et al. Reinterpretation of histology of proximal colon polyps called hyperplastic in 2001. World J Gastroenterol 2009; 15:3767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/40\">",
"      Mattar W, Rex DK. Large sessile adenomas are associated with a high prevalence of synchronous advanced adenomas. Clin Gastroenterol Hepatol 2008; 6:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/41\">",
"      Salama M, Ormonde D, Quach T, et al. Outcomes of endoscopic resection of large colorectal neoplasms: an Australian experience. J Gastroenterol Hepatol 2010; 25:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/42\">",
"      Glazer E, Golla V, Forman R, et al. Serrated adenoma is a risk factor for subsequent adenomatous polyps. Dig Dis Sci 2008; 53:2204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/43\">",
"      Li D, Jin C, McCulloch C, et al. Association of large serrated polyps with synchronous advanced colorectal neoplasia. Am J Gastroenterol 2009; 104:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/44\">",
"      M&auml;kinen MJ. Colorectal serrated adenocarcinoma. Histopathology 2007; 50:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/45\">",
"      Noffsinger AE. Serrated polyps and colorectal cancer: new pathway to malignancy. Annu Rev Pathol 2009; 4:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/46\">",
"      De Jesus-Monge WE, Gonzalez-Keelan C, Cruz-Correa M. Serrated adenomas. Curr Gastroenterol Rep 2009; 11:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/47\">",
"      Song SY, Kim YH, Yu MK, et al. Comparison of malignant potential between serrated adenomas and traditional adenomas. J Gastroenterol Hepatol 2007; 22:1786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/48\">",
"      Jass JR. Serrated route to colorectal cancer: back street or super highway? J Pathol 2001; 193:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/49\">",
"      Rembacken BJ, Fujii T, Cairns A, et al. Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. Lancet 2000; 355:1211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/50\">",
"      Goldstein NS, Bhanot P, Odish E, Hunter S. Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol 2003; 119:778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/51\">",
"      Hawkins NJ, Ward RL. Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst 2001; 93:1307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/52\">",
"      Wong JJ, Hawkins NJ, Ward RL. Colorectal cancer: a model for epigenetic tumorigenesis. Gut 2007; 56:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/53\">",
"      Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007; 50:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/54\">",
"      Spring KJ, Zhao ZZ, Karamatic R, et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 2006; 131:1400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/55\">",
"      Deng G, Bell I, Crawley S, et al. BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer. Clin Cancer Res 2004; 10:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/56\">",
"      Longacre TA, Fenoglio-Preiser CM. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol 1990; 14:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/57\">",
"      Heitman SJ, Ronksley PE, Hilsden RJ, et al. Prevalence of adenomas and colorectal cancer in average risk individuals: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2009; 7:1272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/58\">",
"      Carlsson G, Petrelli NJ, Nava H, et al. The value of colonoscopic surveillance after curative resection for colorectal cancer or synchronous adenomatous polyps. Arch Surg 1987; 122:1261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/59\">",
"      Rex DK, Lehman GA, Hawes RH, et al. Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests. Gastroenterology 1991; 100:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/60\">",
"      Rex DK, Lehman GA, Ulbright TM, et al. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history. Am J Gastroenterol 1993; 88:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/61\">",
"      Rex DK. Colonoscopy: a review of its yield for cancers and adenomas by indication. Am J Gastroenterol 1995; 90:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/62\">",
"      Pendergrass CJ, Edelstein DL, Hylind LM, et al. Occurrence of colorectal adenomas in younger adults: an epidemiologic necropsy study. Clin Gastroenterol Hepatol 2008; 6:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/63\">",
"      Williams AR, Balasooriya BA, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut 1982; 23:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/64\">",
"      Patel K, Hoffman NE. The anatomical distribution of colorectal polyps at colonoscopy. J Clin Gastroenterol 2001; 33:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/65\">",
"      Ben Q, An W, Jiang Y, et al. Body mass index increases risk for colorectal adenomas based on meta-analysis. Gastroenterology 2012; 142:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/66\">",
"      Nam SY, Kim BC, Han KS, et al. Abdominal visceral adipose tissue predicts risk of colorectal adenoma in both sexes. Clin Gastroenterol Hepatol 2010; 8:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/67\">",
"      Wolin KY, Yan Y, Colditz GA. Physical activity and risk of colon adenoma: a meta-analysis. Br J Cancer 2011; 104:882.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/68\">",
"      Nguyen SP, Bent S, Chen YH, Terdiman JP. Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2009; 7:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/69\">",
"      Lieberman DA, Holub JL, Moravec MD, et al. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA 2008; 300:1417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/70\">",
"      Ozick LA, Jacob L, Donelson SS, et al. Distribution of adenomatous polyps in African-Americans. Am J Gastroenterol 1995; 90:758.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/71\">",
"      Karami S, Young HA, Henson DE. Earlier age at diagnosis: another dimension in cancer disparity? Cancer Detect Prev 2007; 31:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/72\">",
"      Saitoh Y, Waxman I, West AB, et al. Prevalence and distinctive biologic features of flat colorectal adenomas in a North American population. Gastroenterology 2001; 120:1657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/73\">",
"      O'brien MJ, Winawer SJ, Zauber AG, et al. Flat adenomas in the National Polyp Study: is there increased risk for high-grade dysplasia initially or during surveillance? Clin Gastroenterol Hepatol 2004; 2:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/74\">",
"      Soetikno R, Friedland S, Kaltenbach T, et al. Nonpolypoid (flat and depressed) colorectal neoplasms. Gastroenterology 2006; 130:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/75\">",
"      Soetikno RM, Kaltenbach T, Rouse RV, et al. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA 2008; 299:1027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/76\">",
"      Kudo S, Tamure S, Nakajima T, et al. Depressed type of colorectal cancer. Endoscopy 1995; 27:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/77\">",
"      Watanabe T, Sawada T, Kubota Y, et al. Malignant potential in flat elevations. Dis Colon Rectum 1993; 36:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/78\">",
"      Colton CG, Sivak MV Jr. Flat adenomas and cancers. Gastrointest Endosc 1995; 42:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/79\">",
"      Kuramoto S, Oohara T. Flat early cancers of the large intestine. Cancer 1989; 64:950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/80\">",
"      Rubio CA, Kato Y, Hirota T, Muto T. Histologic classification of endoscopically removed flat colorectal polyps: a multicentric study. Jpn J Cancer Res 1996; 87:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/81\">",
"      Fujii T, Rembacken BJ, Dixon MF, et al. Flat adenomas in the United Kingdom: are treatable cancers being missed? Endoscopy 1998; 30:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/82\">",
"      Hart AR, Kudo S, Mackay EH, et al. Flat adenomas exist in asymptomatic people: important implications for colorectal cancer screening programmes. Gut 1998; 43:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/83\">",
"      Suzuki N, Saunders BP, Talbot IC. Flat colorectal neoplasms: the incidence in the UK population. Gut 2001; (Suppl I)48:A21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/84\">",
"      Rex DK, Bond JH, Winawer S, et al. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2002; 97:1296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/85\">",
"      Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992; 326:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/86\">",
"      Young GP. Fecal Immunochemical Tests (FIT) vs Office-Based Guaiac Fecal Occult Blood Test (FOBT). Practical Gastroenterology 2004; 28:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/87\">",
"      Bersentes K, Fennerty MB, Sampliner RE, Garewal HS. Lack of spontaneous regression of tubular adenomas in two years of follow-up. Am J Gastroenterol 1997; 92:1117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/88\">",
"      Winawer SJ, Zauber AG, O'Brien MJ, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 1993; 328:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/89\">",
"      Konishi F, Morson BC. Pathology of colorectal adenomas: a colonoscopic survey. J Clin Pathol 1982; 35:830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/90\">",
"      Spencer RJ, Melton LJ 3rd, Ready RL, Ilstrup DM. Treatment of small colorectal polyps: a population-based study of the risk of subsequent carcinoma. Mayo Clin Proc 1984; 59:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/91\">",
"      Otchy DP, Ransohoff DF, Wolff BG, et al. Metachronous colon cancer in persons who have had a large adenomatous polyp. Am J Gastroenterol 1996; 91:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/92\">",
"      Lieberman DA, Weiss DG, Harford WV, et al. Five-year colon surveillance after screening colonoscopy. Gastroenterology 2007; 133:1077.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/93\">",
"      Mart&iacute;nez ME, Baron JA, Lieberman DA, et al. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology 2009; 136:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/94\">",
"      Butterly LF, Chase MP, Pohl H, Fiarman GS. Prevalence of clinically important histology in small adenomas. Clin Gastroenterol Hepatol 2006; 4:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/95\">",
"      Lieberman D, Moravec M, Holub J, et al. Polyp size and advanced histology in patients undergoing colonoscopy screening: implications for CT colonography. Gastroenterology 2008; 135:1100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/96\">",
"      Mart&iacute;nez ME, Sampliner R, Marshall JR, et al. Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology 2001; 120:1077.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/97\">",
"      Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010; 116:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/98\">",
"      Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993; 329:1977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/99\">",
"      Zauber AG, Winawer SJ, O'Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012; 366:687.",
"     </a>",
"    </li>",
"    <li>",
"     Williams CB, Macrae FA. The St. Mark's neoplastic polyp follow-up study. In: The Secondary Prevention of Colorectal Cancer, Rozen P (Ed), Karger, Basel, Switzerland 1986. p.226.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/101\">",
"      Robertson DJ, Greenberg ER, Beach M, et al. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology 2005; 129:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/102\">",
"      Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343:1603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/103\">",
"      Baxter NN, Goldwasser MA, Paszat LF, et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009; 150:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/104\">",
"      Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010; 375:1624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/105\">",
"      Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 2012; 366:2345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/106\">",
"      Waye JD. What is a gold standard for colon polyps? Gastroenterology 1997; 112:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/107\">",
"      Winawer SJ, Stewart ET, Zauber AG, et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N Engl J Med 2000; 342:1766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/108\">",
"      Rex DK, Cutler CS, Lemmel GT, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997; 112:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/109\">",
"      Barclay RL, Vicari JJ, Doughty AS, et al. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med 2006; 355:2533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/110\">",
"      Kaminski MF, Regula J, Kraszewska E, et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010; 362:1795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/111\">",
"      Brenner H, Hoffmeister M, Arndt V, et al. Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst 2010; 102:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/112\">",
"      Peluso F, Goldner F. Follow-up of hot biopsy forceps treatment of diminutive colonic polyps. Gastrointest Endosc 1991; 37:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/113\">",
"      Woods A, Sanowski RA, Wadas DD, et al. Eradication of diminutive polyps: a prospective evaluation of bipolar coagulation versus conventional biopsy removal. Gastrointest Endosc 1989; 35:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/114\">",
"      Walsh RM, Ackroyd FW, Shellito PC. Endoscopic resection of large sessile colorectal polyps. Gastrointest Endosc 1992; 38:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/115\">",
"      Bond JH. Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 2000; 95:3053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/116\">",
"      Atkin WS, Saunders BP, British Society for Gastroenterology, Association of Coloproctology for Great Britain and Ireland. Surveillance guidelines after removal of colorectal adenomatous polyps. Gut 2002; 51 Suppl 5:V6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/117\">",
"      Seitz U, Bohnacker S, Seewald S, et al. Is endoscopic polypectomy an adequate therapy for malignant colorectal adenomas? Presentation of 114 patients and review of the literature. Dis Colon Rectum 2004; 47:1789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/118\">",
"      Cranley JP, Petras RE, Carey WD, et al. When is endoscopic polypectomy adequate therapy for colonic polyps containing invasive carcinoma? Gastroenterology 1986; 91:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/119\">",
"      Cottet V, Jooste V, Fournel I, et al. Long-term risk of colorectal cancer after adenoma removal: a population-based cohort study. Gut 2012; 61:1180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/120\">",
"      Laiyemo AO, Murphy G, Albert PS, et al. Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4 years. Ann Intern Med 2008; 148:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/121\">",
"      Robertson DJ, Burke CA, Welch HG, et al. Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics. Ann Intern Med 2009; 151:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/122\">",
"      Arber N, Eagle CJ, Spicak J, et al. Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 2006; 355:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/123\">",
"      Bertagnolli MM, Eagle CJ, Zauber AG, et al. Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 2006; 355:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/124\">",
"      Baron JA, Sandler RS, Bresalier RS, et al. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology 2006; 131:1674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/125\">",
"      Bresalier RS, Sandler RS, Quan H, et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005; 352:1092.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/126\">",
"      Din FV, Theodoratou E, Farrington SM, et al. Effect of aspirin and NSAIDs on risk and survival from colorectal cancer. Gut 2010; 59:1670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/62/32746/abstract/127\">",
"      Alberts DS, Mart&iacute;nez ME, Hess LM, et al. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J Natl Cancer Inst 2005; 97:846.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2594 Version 16.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-79.122.249.114-3C057D9C1B-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_62_32746=[""].join("\n");
var outline_f31_62_32746=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      NON-NEOPLASTIC POLYPS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26829073\">",
"      Hyperplastic polyps",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Mucosal polyps",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Inflammatory pseudopolyps",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Submucosal polyps",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15416963\">",
"      Hamartomatous polyps",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15416970\">",
"      - Juvenile polyps",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15416977\">",
"      - Peutz-Jeghers polyps",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15416984\">",
"      - Cronkhite-Canada syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5190142\">",
"      Perineuromas/fibroblastic polyps",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14623567\">",
"      NEOPLASTIC POLYPS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26827803\">",
"      Serrated polyps",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26827993\">",
"      - Hyperplastic polyps",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26828020\">",
"      - Serrated polyposis syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26828552\">",
"      - Sessile serrated adenoma/polyps and traditional serrated adenomas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Adenomatous polyps",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Definitions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Epidemiology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Morphologic/endoscopic classification",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Pathologic classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Tubular",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Villous",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Tubulovillous adenomas",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Clinical presentation and natural history",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Risk factors for high-grade dysplasia and cancer",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Detection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Polypectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Approach to management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Surveillance",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2594\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2594|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?33/27/34238\" title=\"diagnostic image 1\">",
"      Villous adenoma BE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2594|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?7/18/7469\" title=\"figure 1\">",
"      Prevalence of polyps with age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?21/61/22494\" title=\"figure 2\">",
"      CRC incidence Natl Polyp Study",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2594|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?34/33/35358\" title=\"picture 1\">",
"      Pseudopolyps IBD Endosc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?37/2/37928\" title=\"picture 2\">",
"      Juvenile colonic polyp Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?34/63/35833\" title=\"picture 3\">",
"      PJS colonic polyp Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?7/50/7968\" title=\"picture 4\">",
"      Cronkhite-Canada syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?29/58/30628\" title=\"picture 5\">",
"      Colonic polyps Endosc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?38/16/39177\" title=\"picture 6\">",
"      Hyperplast colonic polyp Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?27/38/28265\" title=\"picture 7A\">",
"      Colonic adenoma Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?42/57/43922\" title=\"picture 7B\">",
"      Colonic adenoma pseudoinvasion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/4/40000\" title=\"picture 8\">",
"      Cecal villous adenoma Endosc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?32/24/33157\" title=\"picture 9\">",
"      Colonic adenoma cancer Light",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2594|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?2/50/2861\" title=\"table 1\">",
"      Colonoscopy surveillance and screening intervals",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?7/38/7788\" title=\"table 2\">",
"      Molecular classification of CRC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/1/23579\" title=\"table 3\">",
"      Polyp surveillance after first surveillance colonoscopy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/24/42378?source=related_link\">",
"      Cancer prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/0/15370?source=related_link\">",
"      Chromoendoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/39/17016?source=related_link\">",
"      Clinical manifestations and diagnosis of familial adenomatous polyposis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/7/11386?source=related_link\">",
"      Clinical manifestations, diagnosis, and prognosis of ulcerative colitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/25/42394?source=related_link\">",
"      Colorectal cancer: Epidemiology, risk factors, and protective factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/49/36632?source=related_link\">",
"      Computed tomographic colonography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/2/3113?source=related_link\">",
"      Confocal laser endomicroscopy and endocytoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/18/28968?source=related_link\">",
"      Endoscopic removal of large colonic polyps",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/13/1242?source=related_link\">",
"      Endoscopic ultrasound for the characterization of subepithelial lesions of the upper gastrointestinal tract",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/5/29783?source=related_link\">",
"      Lynch syndrome (hereditary nonpolyposis colorectal cancer): Screening and management of patients and families",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/9/4248?source=related_link\">",
"      Magnification endoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/33/30234?source=related_link\">",
"      Molecular genetics of colorectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/8/22666?source=related_link\">",
"      NSAIDs (including aspirin): Role in prevention of cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/6/37990?source=related_link\">",
"      Overview of Peutz-Jeghers syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/49/30489?source=related_link\">",
"      Overview of the management of primary colon cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?25/9/25747?source=related_link\">",
"      Patient information: Colon polyps (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/5/9298?source=related_link\">",
"      Patient information: Colon polyps (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?9/30/9698?source=related_link\">",
"      Patient information: Colonoscopy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?18/11/18611?source=related_link\">",
"      Patient information: Colonoscopy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?20/47/21234?source=related_link\">",
"      Patient information: Familial adenomatous polyposis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?41/12/42176?source=related_link\">",
"      Patient information: Flexible sigmoidoscopy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/24/23946?source=related_link\">",
"      Peripheral nerve tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/9/3224?source=related_link\">",
"      Peutz-Jeghers syndrome and juvenile polyposis: Screening and management of patients and families",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/10/37034?source=related_link\">",
"      Screening for colorectal cancer: Strategies in patients at average risk",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/41/9881?source=related_link\">",
"      Screening for colorectal cancer: Strategies in patients with possible increased risk due to family history",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/61/28634?source=related_link\">",
"      Surveillance after colorectal cancer resection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/9/38042?source=related_link\">",
"      Tests for screening for colorectal cancer: Stool tests, radiologic imaging and endoscopy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_62_32747="Water related antigens in HP";
var content_f31_62_32747=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F53834&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F53834&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Hypersensitivity pneumonitides associated with ventilation and water-related contamination",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Environmental source",
"       </td>",
"       <td class=\"subtitle1\">",
"        Major causative antigen",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"5\">",
"        Humidifier fever",
"       </td>",
"       <td>",
"        Thermoactinomyces (T vulgaris, T sacchari, T candidus)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Klebsiella oxytoca",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Naegleria gruberi",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acanthamoeba polyphaga",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acanthamoeba castellani",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Unventilated shower",
"       </td>",
"       <td>",
"        Epicoccum nigrum",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Hot-tub lung (mists; mold on ceiling and around tub)",
"       </td>",
"       <td>",
"        Cladosporium sp",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mycobacterium avium complex",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sauna taker's lung",
"       </td>",
"       <td>",
"        Aureobasidium sp, other sources",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Summer-type pneumonitis",
"       </td>",
"       <td>",
"        Trichosporon cutaneum",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lifeguard lung",
"       </td>",
"       <td>",
"        Aerosolized endotoxin from pool-water sprays and fountains",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Contaminated basement (sewage) pneumonitis",
"       </td>",
"       <td>",
"        Cephalosporium",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_62_32747=[""].join("\n");
var outline_f31_62_32747=null;
var title_f31_62_32748="Promotion of general knowledge";
var content_f31_62_32748=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F70285&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F70285&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Suggestions for enhancing a child's cognitive and general knowledge skills before kindergarten entry",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Parents can promote cognitive",
"skills by asking their children to place information or objects* into",
"categories according to:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Function",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Size",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Color",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Shape",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kind",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Parents can enhance",
"their child's arithmetic skills by teaching them to:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Count by rote to 100",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Understand number concepts to 10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Comprehend the concept of 'each'",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Identify a circle, triangle, and square",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Comprehend the concepts of",
"'more than, less than, same'",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        \"Identify which group has",
"more/less/the",
"same amount\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Parents can help to",
"increase their children's knowledge of general, musical, artistic,",
"scientific, historical, and literary information by:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Visiting museums, exhibits, zoos, and dramatic theatre",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Listening to audio-books-on-tape",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Viewing videos, television, and",
"illustrated books with their child",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Discussing what they see or hear as",
"they take walks or drive along roadways",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        The following",
"instructional experiences may be beneficial in helping children learn",
"to explain information precisely, respond to questions completely, and",
"increase attention to details:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Describe the attributes and",
"functions of a familiar object or objects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Respond to specific questions",
"related to the name, color, size, use, etc of the object",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Respond to the",
"following questions related to situations, pictures of familiar",
"objects:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        What can you tell me about this?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        What else can you tell me",
"about it?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        What more can you think of to",
"tell me about it?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Are there any",
"other things about it that are important?",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Eg, toys, laundry, groceries, etc.&nbsp;",
"    </div>",
"    <div class=\"reference\">",
"     Adapted in part from recommendations compiled by staff members of the Learning Support Center, Texas Children's Hospital.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_62_32748=[""].join("\n");
var outline_f31_62_32748=null;
var title_f31_62_32749="ACC AHA ETT risk assess CHD";
var content_f31_62_32749=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F64807%7ECARD%2F74428&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F64807%7ECARD%2F74428&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    ACC/AHA guideline summary: Exercise testing for risk assessment and prognosis in patients with an intermediate or high probability of coronary heart disease (CHD)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class I - There is evidence and/or general agreement that exercise testing for risk assessment and prognosis in patients at intermediate or high probability of CHD is indicated in the following settings:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; As part of the initial evaluation in the absence of the exceptions listed in class IIb and class III.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; After a significant change in cardiac symptoms.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class IIb - The usefulness or efficacy is less well established for exercise testing for risk assessment and prognosis in patients at intermediate or high probability of CHD in the following settings:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        &bull;&nbsp; The following ECG abnormalities:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        1. Preexcitation (Wolff-Parkinson-White) syndrome.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        2. Electronically paced ventricular rhythm.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        3. More than 1 mm of ST depression at rest.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        4. Complete left bundle branch block.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; After cardiac catheterization to identify ischemia in the distribution of a coronary lesion of borderline severity.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; After revascularization in patients with a significant change in anginal pattern that is suggestive of ischemia.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class III - There is evidence and/or general agreement that exercise testing for risk assessment and prognosis in patients at intermediate or high probability of CHD is not useful in the following setting:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; In the presence of severe comorbidity that is likely to limit life expectancy or prevent revascularization.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Gibbons, RJ, Abrams, J, Chatterjee, K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 2003; 107:149.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    ACC/AHA guideline summary: Cardiac stress imaging as the initial test for risk stratification of patients with chronic stable angina who are able to exercise",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Class I - There is evidence and/or general agreement that cardiac stress imaging as the initial test for risk stratification of patients with chronic stable angina who are able to exercise should be performed in the following manner:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Among patients who do not have left bundle branch block or an electronically paced ventricular rhythm but have either an abnormal ECG or are taking digoxin, exercise myocardial perfusion imaging (MPI) or exercise echocardiography to identify the extent, severity, and location of ischemia.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Among patients with left bundle branch block or an electronically paced ventricular rhythm, dipyridamole or adenosine MPI.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Among patients with left bundle branch block, dobutamine stress echocardiography.*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; When assessing the functional significance of coronary lesions, exercise MPI or exercise echocardiography.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Class IIb - The weight of evidence or opinion is less well established for the usefulness of cardiac stress imaging as the initial test for risk stratification of patients with chronic stable angina who are able to exercise in the following setting:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Exercise echocardiography in the presence of left bundle branch block.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Exercise, dipyridamole, or adenosis MPI or exercise or dobutamine echocardiography in patients who have a normal rest ECG and are not taking digoxin.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Class III - There is evidence and/or general agreement that cardiac stress imaging as the initial test for risk stratification of patients with chronic stable angina who are able to exercise is not useful in in the following settings:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Exercise MPI in the presence of left bundle branch block.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Severe comorbidity that is likely to limit life expectation or prevent revascularization.",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Modified from: Fleisher, LA, Beckman, JA, Brown, KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007; 116:e418.",
"    </div>",
"    <div class=\"reference\">",
"     Data from Gibbons, RJ, Abrams, J, Chatterjee, K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 2003; 107:149. Copyright 2003 by the American College of Cardiology and American Heart Association, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_62_32749=[""].join("\n");
var outline_f31_62_32749=null;
var title_f31_62_32750="Contents: Pituitary disease";
var content_f31_62_32750=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?1/56/1934\">",
"       Endocrinology and Diabetes",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Pituitary disease",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Pituitary disease",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Antidiuretic hormone",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/10/16552\">",
"           Chapter 6B: Antidiuretic hormone and water balance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/35/21048\">",
"           Clinical manifestations and causes of central diabetes insipidus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/47/24312\">",
"           Diagnosis of polyuria and diabetes insipidus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/46/7913\">",
"           Pathophysiology and etiology of the syndrome of inappropriate antidiuretic hormone secretion (SIADH)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/31/505\">",
"           Treatment of central diabetes insipidus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/57/17306\">",
"           Treatment of hyponatremia: Syndrome of inappropriate antidiuretic hormone secretion (SIADH) and reset osmostat",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/34/6691\">",
"           Urine output in diabetes insipidus",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Growth hormone",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/3/30776\">",
"           Causes and clinical manifestations of acromegaly",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/18/10537\">",
"           Causes of short stature",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/4/43076\">",
"           Diagnosis of acromegaly",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/60/18376\">",
"           Diagnostic approach to short stature",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/50/1833\">",
"           Growth hormone deficiency in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/6/17509\">",
"           Growth hormone metabolism in chronic kidney disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/1/43030\">",
"           Physiology of growth hormone",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/9/13464\">",
"           Pituitary gigantism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/54/7015\">",
"           Rheumatic and bone disorders associated with acromegaly",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/9/7322\">",
"           Treatment of acromegaly",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypogonadism",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/18/8488\">",
"           Causes of secondary hypogonadism in males",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/7/2170\">",
"           Congenital gonadotropin-releasing hormone deficiency (idiopathic hypogonadotropic hypogonadism)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/61/23510\">",
"           Induction of fertility in men with secondary hypogonadism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/32/1545\">",
"           Testosterone treatment of male hypogonadism",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypopituitarism",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/38/9833\">",
"           Causes of hypopituitarism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/39/31348\">",
"           Clinical manifestations of hypopituitarism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/7/2170\">",
"           Congenital gonadotropin-releasing hormone deficiency (idiopathic hypogonadotropic hypogonadism)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/28/41413\">",
"           Diagnosis of hypopituitarism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/22/28006\">",
"           Treatment of hypopituitarism",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Miscellaneous",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/7/2170\">",
"           Congenital gonadotropin-releasing hormone deficiency (idiopathic hypogonadotropic hypogonadism)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/30/25059\">",
"           Hypothalamic-pituitary axis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/46/13034\">",
"           Physiology and clinical use of melatonin",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pituitary tumors",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/3/30776\">",
"           Causes and clinical manifestations of acromegaly",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/41/22167\">",
"           Causes of hyperprolactinemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/18/29992\">",
"           Causes, presentation, and evaluation of sellar masses",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/61/22489\">",
"           Clinical manifestations and diagnosis of gonadotroph and other clinically nonfunctioning pituitary adenomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/60/24520\">",
"           Craniopharyngioma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/4/43076\">",
"           Diagnosis of acromegaly",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/6/17509\">",
"           Growth hormone metabolism in chronic kidney disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/43/12981\">",
"           Incidentally discovered sellar masses (pituitary incidentalomas)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/34/41510\">",
"           Management of lactotroph adenoma (prolactinoma) during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/54/7015\">",
"           Rheumatic and bone disorders associated with acromegaly",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/20/327\">",
"           Thyrotropin (TSH)-secreting pituitary adenomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/9/7322\">",
"           Treatment of acromegaly",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/41/8857\">",
"           Treatment of gonadotroph and other clinically nonfunctioning adenomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/52/31561\">",
"           Treatment of hyperprolactinemia due to lactotroph adenoma and other causes",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Prolactin",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/41/22167\">",
"           Causes of hyperprolactinemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/51/19254\">",
"           Clinical manifestations and diagnosis of hyperprolactinemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/34/41510\">",
"           Management of lactotroph adenoma (prolactinoma) during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/52/31561\">",
"           Treatment of hyperprolactinemia due to lactotroph adenoma and other causes",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-A848493F8B-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f31_62_32750=[""].join("\n");
var outline_f31_62_32750=null;
var title_f31_62_32751="Dorsal ganglion aspiration";
var content_f31_62_32751=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F71977&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F71977&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Diagnostic aspiration of the dorsal ganglion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 356px; height: 287px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The wrist is positioned flat on the table, palm side down. A 1 inch, 18-gauge needle is inserted at the base of the cyst to a depth of 1/4 to 3/8 inch, and the tenacious fluid is aspirated.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bruce C Anderson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_62_32751=[""].join("\n");
var outline_f31_62_32751=null;
